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Summary 
 
Nicastrin is one out of four components of γ-secretase, a membrane protein complex with a 
key role in the pathogenesis of Alzheimer’s Disease. Its closest relative is Nicalin (Nicastrin-
like protein) which, together with NOMO (Nodal modulator), is part of a novel, evolutionary 
conserved membrane protein complex which is involved in the regulation of the Nodal 
signaling pathway in developing zebrafish embryos. Since its native size (200-220 kDa) 
could not be satisfyingly explained by the molecular weights of monomeric Nicalin (60 kDa) 
and NOMO (130 kDa), the possible existence of additional components, especially in the 
low-molecular-weight range, was examined. Using an optimized procedure of the Nicalin 
affinity purification approach which had led to the isolation of NOMO, a ~22-kDa protein 
could be specifically enriched from membrane protein lysates of cultured human cells and 
identified by mass spectrometry as transmembrane protein 147 (TMEM147). TMEM147 is a 
novel, highly conserved polytopic membrane protein with a putative topology similar to the γ-
secretase component APH-1. Its specific interaction with Nicalin was confirmed by 
immunoprecipitation/immunoblotting experiments and shown to be roughly stoichiometric. 
Immunofluorescence microscopy and density gradient centrifugation studies demonstrated a 
colocalization with Nicalin in the endoplasmic reticulum. mRNA in situ hybridization studies in 
zebrafish embryos revealed a ubiquitous expression during all developmental stages, in 
agreement with the distribution of Nicalin and NOMO. Gain-of-function and loss-of-function 
experiments in cultured cells demonstrated a mutual dependence in the expression levels 
between the three proteins further corroborating the idea that they are components of the 
same complex. A variety of data indicated that, like γ-secretase, the assembly of this 
complex is hierarchical beginning with the formation of a Nicalin-NOMO intermediate. Nicalin 
appears to represent the limiting factor and to regulate the assembly rate by stabilizing 
NOMO and TMEM147. In summary, the presented data identify TMEM147 as a novel core 
component of the Nicalin-NOMO complex with a structural relationship to APH-1. When the 
Nicalin purification procedure was combined with stable isotope labeling using amino acids in 
cell culture (SILAC) and a comprehensive mass spectrometry analysis, a variety of additional 
Nicalin interactors were identified. A few of them were confirmed by co-immunoprecipitation 
assays and likely represent transient binding partners which might mediate the cellular 
function of the Nicalin-NOMO complex. Future studies are required to analyze the relevance 
of these interactions in detail. 
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Zusammenfassung 
 
 
Nicastrin ist eine von vier Komponenten der γ-Sekretase, eines Membranprotein-Komplexes 
mit einer Schlüsselrolle bei der Entstehung der Alzheimerschen Demenz. Sein nächster 
Verwandter ist Nicalin (Nicastrin-like protein), gemeinsam mit NOMO (Nodal modulator) Be-
standteil eines neuartigen, evolutionär konservierten Membranproteinkomplexes, der 
offenbar eine Rolle im Nodal-Signalweg während der Zebrafisch-Embryonalentwicklung 
spielt. Da die native Größe des Komplexes (200-220 kDa) nicht hinreichend mit den 
Molekulargewichten der Monomere von Nicalin (60 kDa) und NOMO (130 kDa) erklärt 
werden konnte, wurde der Komplex auf mögliche zusätzliche Komponenten, insbesondere 
im niedermolekularen Bereich, hin untersucht. Durch Optimierung der Nicalin-
Affinitätsreinigung, die bereits zur Isolation von NOMO geführt hatte, konnte ein ~22-kDa-
Protein spezifisch in Membranproteinlysaten kultivierter humaner Zellen angereichert und 
mittels Massenspektrometrie als Transmembranprotein 147 (TMEM147) identifiziert werden. 
TMEM147 ist ein neuartiges, hochkonserviertes polytopisches Membranprotein mit einer 
mutmaßlichen Topologie, die der der γ -Secretase-Komponente APH-1 ähnelt. Die 
spezifische Interaktion mit Nicalin, die in etwa in stöchiometrischen Verhältnissen erfolgt, 
konnte mittels Immunpräzipitations/Immunblot-Studien bestätigt werden. Immunfluoreszenz-
Mikroskopie- und Dichtegradienten-Zentrifugations-Experimente legen eine Kolokalisation 
mit Nicalin im endoplasmatischen Retikulum nahe. mRNA-in-situ-Hybridisierung in 
Zebrafischembryonen zeigte eine ubiquitäre Expression in allen Entwicklungsstadien, im 
Einklang mit der Verteilung von Nicalin und NOMO. Überexpressions- und 
Depletionsversuche in kultivierten humanen Zellen demonstrierten eine wechselseitige Ab-
hängigkeit der Expressionsspiegel der drei Proteine, was ihre Zugehörigkeit zu ein und dem-
selben Proteinkomplex unterstreicht. Eine ganze Reihe von Daten legte nahe, dass - ähnlich 
der γ-Sekretase – der Zusammenbau dieses Komplexes ein hierarchischer Vorgang ist, der 
mit der Ausbildung eines Nicalin/NOMO-Intermediats beginnt. Nicalin ist offenbar der 
limitierende Faktor, der - indem er NOMO und TMEM147 stabilisiert - den Aufbau des 
Komplexes reguliert. In ihrer Gesamtheit weisen die präsentierten Daten TMEM147 als eine 
neue Kernkomponente des Nicalin-NOMO-Komplexes mit einer strukturellen Verwandtschaft 
zu APH-1 aus. Durch eine Kombination der Nicalin-Aufreinigung mit SILAC (stable isotope 
labeling using amino acids in cell culture) und einer umfassenden massenspektrometrischen 
Analyse konnte eine Reihe weiterer Interaktoren identifiziert werden. Einige von ihnen 
wurden durch Kopräzipitationsstudien bestätigt und stellen wahrscheinlich transiente 
Bindungspartner dar, die möglicherweise die zelluläre Funktion des Nicalin-NOMO-
Komplexes vermitteln. Zukünftige Studien sind erforderlich, um die Relevanz dieser Interak-
tionen im Detail zu analysieren. 
  Introduction 
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1  Introduction 
 
1.1 γ-Secretase 
 
Alzheimer's disease (AD) is the most common form of dementia (reviewed by Selkoe, 2001). 
One of its pathological hallmarks is the accumulation of amyloid plaques, large 
proteinaceous deposits, in certain areas of the brain (Fig. 1). They primarily consist of 
aggregated forms of the amyloid β-peptide (short: Aβ), a proteolytic cleavage product of the 
β-amyloid precursor protein (APP). Aβ exists in several forms: a major 40 amino acid form 
(Aβ40), and less dominant forms like Aβ42, Aβ38, and Aβ43 (Wiltfang et al., 2002). In 
particular the accumulation of the highly aggregation-prone Aβ42 has been shown to be 
central for the generation of the amyloid plaques (reviewed by Hardy and Selkoe, 2002). The 
plaques have been associated with pathological events like local synaptic abnormalities and 
breakage of neuronal processes (e.g., Tsai et al., 2004), but many studies suggest a plaque-
independent pathological role of Aβ oligomers, soluble aggregates of much lower molecular 
weight, which for example could be shown to interfere with memory in animal models (Walsh 
et al., 2002; Cleary et al., 2005; Shankar et al., 2007). In patients with familial AD (FAD), an 
inherited form of the disease with an early age of onset, Aβ42 accumulation is accelerated 
due to mutations resulting in an increased Aβ42/Aβ40 ratio or overall Aβ production 
(reviewed by Hardy, 1997). FAD mutations have been found in APP and in two additional 
genes: Presenilin 1 and 2, which code for proteases involved in APP processing (see below).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The APP protein, whose physiological function is only incompletely understood, is present at 
the surface of most cell types. It is a type-I transmembrane protein with a large amino-
 
 
  
  
 
 
APP 
    
  
  
Aβ 
Aβ oligomers 
amyloid plaque 
Fig. 1: Aβ generation from APP via proteolytic processing (for further details, see text). The APP ectodomain is first 
shedded by β-secretase (β-sec.) releasing APPsβ (not shown). The remaining membrane-bound β-C-terminal fragment (β-CTF) 
is then further processed by γ-secretase (γ-sec.) within the membrane, releasing Aβ to the extracellular space and the APP 
intracellular domain (AICD) to the cytosol. Aβ aggregates at first to oligomers, which are finally deposited in amyloid plaques. 
Adapted from Haass, 2004.  
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terminal extracellular domain and a short carboxy-terminal cytosolic domain (Fig. 1). Its 
processing to generate Aβ includes two major steps, a β-cleavage and a subsequent γ-
cleavage (reviewed by Steiner and Haass, 2000; Haass, 2004). The β-cleavage is performed 
by the β-secretase BACE (β-site APP-cleaving enzyme) causing the release of most of the 
extracellular domain in the form of APPsβ (APP soluble β) from the cell (reviewed by Vassar, 
2004). After this so-called ectodomain shedding, the remaining membrane-bound β-C-
terminal fragment (β-CTF) undergoes an unusual intramembrane cleavage, carried out by γ-
secretase (reviewed by Hardy and Selkoe, 2002; Sisodia and St George-Hyslop, 2002), 
resulting in the generation of Aβ, which is secreted into the extracellular space, and APP 
intracellular domain, AICD (reviewed by Haass and Steiner, 2002).  
Beyond the cleavage of APP CTFs, γ-secretase catalyzes the intramembrane proteolysis of 
other type-I plasma membrane proteins, which have undergone shedding, most importantly 
the signaling receptor Notch (reviewed by Selkoe and Kopan, 2003). In a zebrafish study 
(Geling et al., 2002), for example, γ-secretase inhibition by drug treatment (DAPT) was 
shown to phenocopy Notch pathway mutants (van Eeden et al., 1996; Jiang et al., 2000), 
characterized by the malformation of somites, primitive segments in the developing 
vertebrate embryo distributed along the two sides of the developing spinal cord (Fig. 2). The 
Notch signaling pathway is initiated by the binding of an extracellular ligand, Delta-like or 
Jagged, to the Notch receptor resulting in the shedding of the Notch extracellular domain 
(reviewed by Fortini, 2002). The remaining Notch fragment is then cleaved by γ-secretase 
generating Notch-β, the pendant of Aβ, and the Notch intracellular domain (NICD), which 
translocates to the nucleus and activates the transcription of Notch target genes in concert 
with other transcriptional regulators (reviewed by Mumm and Kopan, 2000). This pathway is 
highly conserved during evolution and indispensible for a variety of cell-cell communication 
events in multicellular organisms, especially for fundamental cell differentiation processes 
during embryonic development, but also in adult organisms (reviewed by Mumm and Kopan, 
2000). Notch signaling is dysregulated in many cancers (www.healthvalue.net/notch.html).  
 
 
 
 
 
 
 
 
 
B 
Fig. 2: Zebrafish embryos treated with the γ-secretase inhibitor DAPT show a Notch phenotype (adapted from Geling et 
al., 2002). Mock-treated (A) and DAPT-treated (B) embryos visualized at 24 hours post fertilization (live views, close-up views of 
the tail). DAPT treatment alters somitic borders [arrows in (A) and (B)]. An overview picture of a ~24 hours old embryo was 
added (C, source: www.zf-models.org), indicating the approximate origin of the detail pictures.  
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1.1.1 Components of γ-secretase 
γ-Secretase is not a single protein, but rather a protein complex. It is assembled in the 
endoplasmic reticulum (ER) and subsequently transported to the plasma membrane (see 
section 1.1.2). Genetic and biochemical studies have identified four membrane proteins as γ-
secretase components (Fig. 3): Nicastrin, APH-1 (Anterior Pharynx-Defective 1), PEN-2 
(Presenilin-Enhancer 2) and Presenilin 1/2 (for references, see below). A 1:1:1:1 composition 
of the components in the high-molecular-weight protein complex, leading to a molecular 
weight of 200 to 250 kDa, is likely (Sato et al., 2007), but requires further investigation. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenilin (PS) is the catalytic subunit of γ-secretase (see below). In mammals, the two 
homologs PS1 and PS2 with 63 % sequence homology exist (Yu et al., 1998). PS1 knockout 
mice show a strongly reduced γ-secretase activity (De Strooper et al., 1998; Naruse et al., 
1998). Membrane topology studies identified PS as a polytopic 9 transmembrane domain 
(TMD) protein with its N-terminus and a large loop facing the cytosolic side and its C-
terminus facing the extracellular/luminal side (Kaether et al., 2004; Laudon et al., 2005; Oh 
and Turner, 2005; Sobhanifar et al., 2010). The TMDs 6 and 7 contain two highly conserved 
aspartate residues leading to the idea PS might represent an aspartic protease, and indeed, 
the mutagenesis of the conserved aspartate residues was demonstrated to abrogate enzyme 
activity (Steiner et al., 1999; Wolfe et al., 1999; Kimberly et al., 2000). Moreover, aspartic 
protease inhibitors could be shown to inhibit γ-secretase activity (Wolfe et al., 1999; 
Shearman et al., 2000). Being an unusual aspartic protease, PS does not contain the 
classical aspartic protease motif, D(T/S)G(T/S), but rather novel active site motifs, the GxGD 
motif around the critical aspartate in TMD7 and a YD motif in TMD6 (Steiner et al., 2000; 
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Fig. 3: The components of γ-secretase. The complex consists of the small hairpin-like PEN-2, the catalytically active 
Presenilin, the type-I transmembrane protein Nicastrin and the polytopic APH-1. In mature γ-secretase, PS has been 
autocatalytically cleaved into N-terminal fragment (NTF) and C-terminal fragment (CTF), and Nicastrin is complex glycosylated 
(indicated by the ‘Y’s). The PS transmembrane domains 6 and 7 contain two highly conserved aspartate (D) residues, critical for 
the catalytic activity of the complex, which represents an aspartic protease. Nicastrin may represent the substrate receptor, with 
a critical aspartate at amino acid position 333 in humans (E333) being involved in substrate binding.   
extracellular space  
cytosol 
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reviewed by Steiner and Haass, 2000). In the mature γ-secretase complex PS exists in an N- 
and C-terminal fragment (Thinakaran et al., 1996), which are generated by endoproteolysis 
(Fukumori et al., 2010) and remain stably associated as heterodimers (Capell et al., 1998; Yu 
et al., 1998; Saura et al., 1999). 
Nicastrin (NCT), a ~110 kDa type-I membrane protein, was identified as a PS1/2 interactor 
by co-immunoprecipitation studies (Yu et al., 2000). It is the largest γ-secretase component 
and the only one with a pronounced extracellular domain. During γ-secretase transport 
through the secretory pathway, NCT undergoes complex asparagine (N)-linked glycosylation 
leading to complex glycosylated NCT, which characterizes mature γ-secretase (Yu et al., 
2000; Kaether et al., 2002; Herreman et al., 2003). NCT contains a functionally important 
DAP (DYIGS and peptidase) domain, an extracellular region of about 200 amino acids with a 
predicted structure similar to domains in aminopeptidases (Fagan et al., 2001; see Fig. 6). 
Mutations in the DYIGS motif reduce both PS/NCT interaction and Aβ production (Yu et al., 
2000; Chen et al., 2001; Shirotani et al., 2004). Also located within the DAP domain, the 
carboxyl group of the glutamate at position 333 (E333; see Fig. 3) has been proposed to 
mediate the interaction with the free N-termini of shedded substrates (Shah et al., 2005; 
Dries et al., 2009). However, it has also been suggested that complex maturation rather than 
substrate recognition is affected when the critical glutamate is mutated (Chavez-Gutierrez et 
al., 2008). 
PEN-2 (Presenilin enhancer 2), a 12 kDa hairpin-like membrane protein, was identified in a 
genetic screen for PS enhancers in a C. elegans strain partially deficient in the function of 
Sel-12, the C. elegans homolog of PS1 (Francis et al., 2002). Co-immunoprecipitation and 
RNAi studies confirmed it as a γ-secretase complex component (Steiner et al., 2002). PEN-2 
was shown to bind to the TMD4 of PS1 (Kim and Sisodia, 2005; Watanabe et al., 2005) and 
to be required for γ-secretase complex maturation. It triggers the endoproteolysis of PS1/2 
(Takasugi et al., 2003) and subsequently stabilizes the PS NTF and CTF in the complex 
(Hasegawa et al., 2004; Prokop et al., 2004). An involvement of PEN-2 in export of γ-
secretase is discussed in section 1.1.2.  
APH-1 (Anterior Pharynx-Defective 1) is a 20 kDa 7-TMD protein (Fortna et al., 2004) 
identified in two independent C. elegans screens (Francis et al., 2002; Goutte et al., 2002). It 
was shown to interact with NCT and PS (Lee et al., 2002). In humans, the two paralogs APH-
1a and APH-1b exist, with APH-1a occuring in the two splice variants APH-1aS and APH-
1aL (Francis et al., 2002; Goutte et al., 2002). APH-1 has been shown to be important for γ-
secretase complex formation acting as an assembly scaffold (Gu et al., 2003; Hu and Fortini, 
2003; LaVoie et al., 2003; Capell et al., 2005; see also section 1.1.2).  
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1.1.2 Assembly and transport of γ-secretase 
Increased γ-secretase levels, accompanied by an elevated γ-secretase activity, can only be 
achieved by the ectopic co-expression of all four components (Edbauer et al., 2003; Hu and 
Fortini, 2003; Kimberly et al., 2003). This suggested that the γ-secretase assembly is tightly 
controled and that the expression levels of its components are balanced under wild-type 
conditions. Forced expression of PS alone, for example, results in a replacement of 
endogenous PS, i.e. the reduction of endogenous PS fragments and increased amounts of 
unincorporated full-length PS, which is less stable than its fragments (Thinakaran et al., 
1997). It was proposed that the γ-secretase components are stabilized by complex formation 
and that unincorporated molecules are rapidly degraded (Thinakaran et al., 1997). This 
hypothesis was confirmed by a variety of loss-of-function studies, which demonstrated that 
downregulation of one component destabilizes at least one other component. For example, 
in NCT knockout embryonic fibroblasts levels of APH-1, PEN-2 and PS fragments are 
drastically decreased (Zhang et al., 2005), while RNAi-mediated PEN-2 downregulation in 
human embryonic kidney cells is associated with reduced PS levels, impaired NCT 
maturation and deficient γ-secretase formation (Steiner et al., 2002). In PS1 knockout 
embryonic fibroblasts, unincorporated immature NCT accumulates, which is less stable than 
the incoporated mature protein (Edbauer et al., 2002; He et al., 2007). Unincorporated PEN-
2, APH-1, NCT, and full-length PS were observed to be degraded mainly by the proteasome, 
but also lysosomal pathways may contribute (Zhang et al., 2005; He et al., 2007). 
Models for γ-secretase assembly and transport (reviewed by Kaether et al., 2006; Spasic 
and Annaert, 2008) agree on the initial formation of a subcomplex consisting of APH-1 and 
immature NCT (Hu and Fortini, 2003; LaVoie et al., 2003). In the next step, full-length PS is 
stabilized within the ER by binding to NCT/APH-1 in a trimeric, inactive complex (LaVoie et 
al., 2003; Kim et al., 2004; Capell et al., 2005). Finally, PEN-2 binds, facilitating PS 
endoproteolysis and γ-secretase activation (LaVoie et al., 2003; Niimura et al., 2005). The 
assembled complex is released from the ER, travels through the Golgi compartments, where 
NCT maturation occurs (Yu et al., 2000; Kaether et al., 2002; Herreman et al., 2003), and is 
further transported to its functional sites, plasma membrane and late secretory pathway 
compartments (Kaether et al., 2002; Capell et al., 2005; Chyung et al., 2005). However, little 
is known about the exact control of these events. None of the four components could be 
identified as the universal rate-limiting factor (Kimberly et al., 2002). ER-retention/retrieval 
signals were identified in PS and PEN-2 and their masking upon complex formation has been 
proposed to allow the ER exit of fully assembled γ-secretase (Kaether et al., 2004; Fassler et 
al., 2010). Fig. 39 in section 3.2 illustrates the assembly of γ-secretase.  
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1.2 The Nicalin-NOMO complex 
 
Like γ-secretase, the Nicalin-NOMO complex is a high-molecular-weight membrane protein 
complex. It was identified only recently and consists of the two membrane proteins Nicalin 
(Nicastrin-like protein) and NOMO (Nodal modulator) (see section 1.2.1), with the former 
being the closest relative of the γ-secretase component Nicastrin (Haffner et al., 2004). 
Studies in zebrafish embryos suggest that the complex is involved in the regulation of the 
Nodal signaling pathway (reviewed by Haffner and Haass, 2004). Nodals are cytokines, i.e. 
secreted ligands for specific receptors involved in cellular growth and differentiation 
(reviewed by Massague, 1998). They are members of the transforming growth factor β 
(TGFβ) superfamily which, in addition to TGFβ itself, includes Activin/Inhibin, Bone 
Morphogenic Proteins (BMPs) and Lefty proteins. Nodals are especially important for 
patterning events during early vertebrate embryogenesis, e.g. mesoderm (and endoderm) 
formation, ventral midline formation, anterior-posterior patterning and anterior-posterior axis 
positioning (reviewed by Schier and Shen, 2000). Thus, in developing embryos their overall 
function consists in controling germ layer development and formation of the major body axes 
(reviewed by Schier, 2003). However, they have also been reported to play a role in 
tumorigenesis in adult organisms (reviewed by Strizzi et al., 2009), in particular a contribution 
to melanoma aggressiveness has been postulated (Topczewska et al., 2006).  
Simultaneous ectopic expression of Nicalin and NOMO in zebrafish embryos resulted in 
partial cyclopia (Fig. 4; Haffner et al., 2004), a phenotype indicative of reduced Nodal 
signaling resulting from defective forebrain formation due to a failure in pattern formation in 
the axial mesoderm (Blader and Strahle, 1998). Injection of nomo antisense oligonucleotides 
in fertilized oocytes led to an increase in anterior axial mesoderm (involved in forebrain 
induction) - again a Nodal-specific phenotype, this time due to enhanced Nodal signaling. In 
addition, this effect could be prevented by overexpression of Lefty1, an established Nodal 
inhibitor (Fig 5). These results suggested that the Nicalin-NOMO complex acts as Nodal 
antagonist. 
 
 
 
 
 
 
 
Fig. 4: Nicalin and NOMO inhibit Nodal signaling during zebrafish development. Morphology of wild-type (left) and zebrafish 
embryos after injection of nicalin and nomo capped mRNA (right), 36 hours post fertilization (adapted from Haffner et al., 2004). 
The resulting partial cyclopia is relatively specific for reduced Nodal signaling and results from defective forebrain formation due 
to a failure in mesoderm pattern formation. 
+ ncl, + nomo 
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By binding to receptors on target cells, Nodal factors initiate signaling cascades that result in 
the transcription of specific genes affecting cell proliferation and cell migration. Nodal ligands 
use a mechanism similar to that of other TGFβ superfamily members to initiate signal 
transduction (Fig. 5). The events taking place upon Nodal activation can be divided into four 
steps (reviewed by Shi and Massague, 2003): 
1. A Nodal dimer binds to a heterodimer of membrane-bound type-I (ALK4 in Fig. 5) and 
type-II (ActRIIB in Fig. 5) serine/threonine kinase receptors. In contrast to other TGFβ 
superfamily members, Nodal needs a co-receptor of the Epidermal Growth Factor-Cripto-
FRL1-Cryptic (EGF-CFC) protein family (Oep/Cripto in Fig. 5) for efficient binding. 
2. A ligand-receptor complex forms, in which the type-II receptor kinase activates the type-I 
receptor by phosphorylation of its cytosolic kinase domain.  
3. Activated type-I receptors phosphorylate soluble downstream effectors called Smads. 
The direct targets are Smad2 or Smad3 (R-Smads), which upon phosphorylation form 
heterocomplexes with Smad4 (Co-Smad).  
4. The activated R-Smad/Co-Smad heterocomplexes translocate into the nucleus. Here 
they interact with other transcription factors leading to the expression of specific genes.  
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Fig. 5: The Nodal signaling pathway within the signal receiving cell (for details, see text). An inhibition of the pathway by 
the established inhibitor Lefty is illustrated. Furthermore, a modulation by the ER-located Nicalin and NOMO is indicated, 
focussing on a possible effect on extracellular and transmembrane proteins. In principle, also a Nicalin and NOMO function in 
the Nodal signal sending cell is possible. 
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Considering the critical role of Nodal signals in various aspects of vertebrate embryonic 
development, precise temporal and spatial control of this pathway appears necessary, 
involving dozens of intracellular factors (reviewed by Tian and Meng, 2006). Still, only a few 
antagonists have been identified so far (Tab. 1), including secreted ligands forming 
heterodimers with Nodal proteins (Yeo and Whitman, 2001), secreted long-range antagonists 
binding to both ligands and (co-)receptors (Chen and Schier, 2002; Sakuma et al., 2002; 
Cheng et al., 2004), specific membrane-bound competitors for binding to the EGF-CFC co-
receptor (Harms and Chang, 2003), intracellular transcriptional repressors (Iratni et al., 2002; 
Bell et al., 2003), and mediators of the degradation of Nodal receptors (Zhang et al., 2004). 
The Nicalin-NOMO complex localizes to the membrane of the endoplasmic reticulum (ER) 
and might, therefore, inhibit Nodal signaling by modifying or trapping Nodal signaling 
components that are routed through the ER (Fig. 5, Tab. 1).  
 
 
Tab. 1: Summary of Nodal antagonists (adapted from a review by Tian and Meng, 2006) 
 
 
However, the ubiquitous expression of Nicalin and NOMO as well as their evolutionary con-
servation indicate that the complex may have additional functions beyond Nodal signaling. 
This could be involvement in other TGFβ superfamily pathways (many Nodal antagonists 
also inhibit other related signaling pathways) or even in unrelated events. γ-Secretase might 
serve as a precedent for this idea: Its manipulation in embryonic development leads to 
Notch-related phenotypes, but its function goes beyond Notch signaling. 
 
 
Factor 
 
Type Antagonistic mechanism 
 
Cerberus/Dan 
family members 
 
 
secreted proteins 
 
binding to Nodal proteins and thus prevention of their 
signal transduction (Hashimoto et al., 2004) 
Bmp3/Bmp7 secreted proteins formation of heterodimers with Nodal proteins resulting in 
mutual inhibition (Yeo and Whitman, 2001) 
 
Lefty proteins secreted proteins inhibition of Nodal signal transduction by binding to the 
Nodal co-receptors EGF-CFCs as well as to the Nodal 
ligands (Branford and Yost, 2002) 
 
Tomoregulin-1 transmembrane 
proteins 
binding to EGF-CFCs to prevent the Nodal signal 
transduction (Harms and Chang, 2003) 
 
Dapper2 endosomal protein promotion of the degradation of Nodal receptors (Zhang et 
al., 2004) 
 
Drap1 
 
 
Nicalin/NOMO 
transcriptional 
repressor 
 
ER transmembrane  
proteins  
 
binding to the DNA binding domain of FoxH1 (Iratni et al., 
2002) 
 
possibly modifying or trapping Nodal signaling components 
that are routed through the ER (Haffner et al., 2004) 
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1.2.1 Components of the Nicalin-NOMO complex 
Nicalin was identified in 2004 as the most closely related relative of Nicastrin by a 
bioinformatical approach focussing on the conservation of the DYIGS and aminopeptidase 
(DAP) domain (see section 1.1.1) (Haffner et al., 2004). Due to its homology, which is 
illustrated in Fig. 6, the protein was termed Nicalin, Nicastrin-li
 
ke protein. Like Nicastrin, 
Nicalin is catalytically inactive as, within the DAP domain, the aminoacids required for 
aminopeptidase activity are not conserved in either of the two proteins. Neither the DYIGS 
motif nor the critical glutamate residue (E333, see section 1.1.1), which are important for 
Nicastrin function, are conserved in Nicalin. 
 
 
 
 
 
 
 
 
 
Similar to Nicastrin, Nicalin is a type-I transmembrane protein and ubiquitously expressed 
(Haffner et al., 2004, 2007). It contains N-linked oligosaccharides which do not undergo 
maturation indicating that Nicalin is not transported beyond the early secretory pathway 
(Haffner et al., 2004; Fig. 7). This was confirmed by immunofluorescence microscopy and 
subcellular fractionation showing that Nicalin localizes to the ER (Haffner et al., 2004, 2007). 
Charged amino acids at the Nicalin C-terminus (‘KAKTQ’, Fig. 7) could be responsible for ER 
retention/retrieval.  
 
 
 
 
 
 
Fig. 7: Nicalin protein structure. Nicalin is a type-I transmembrane protein and contains a (catalytically inactive) 
aminopeptidase (AP) domain (in grey) and a transmembrane (TM) domain (in black). The observed N-glycosylation may occur 
at two potential sites that have been predicted (‘Y’). The immature protein has a signal peptide (SP, underlined) for translation 
into the ER. An amino acid sequence that is located at its C-terminus (‘KAKTQ’) may represent an ER-localization signal. 
 
Despite the homology to Nicastrin, Nicalin cannot be co-isolated with γ-secretase and is not 
able to rescue the assembly of a functional γ-secretase complex in cells lacking Nicastrin, 
demonstrating that it is not a γ-secretase component (Haffner et al., 2004). Nevertheless, 
Fig. 6: Nicalin is distantly related to Nicastrin. Sequence alignment of the aminopeptidase domains of Nicalin and Nicastrin 
from man, mouse and zebrafish. Conserved residues are boxed. Residues required for catalytic activity of aminopeptidases are 
shown on top of the alignment and the corresponding residues in Nicalin and Nicastrin are shaded. As the required residues are 
only partially conserved, both Nicalin and Nicastrin are catalytically inactive. Adapted from Haffner et al., 2004 
 
 
563 
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Nicalin was found to be part of a high-molecular-weight membrane protein complex in Blue-
Native PAGE (polyacrylamide gel electrophoresis) raising the possibility that Nicalin might 
have a function analogous to Nicastrin’s role in a novel protein complex (Haffner et al., 
2004). This finding triggered a search for Nicalin binding proteins which could be additional 
components of this novel complex. Membrane protein preparations were used for a large-
scale immunoprecipitation of Nicalin and analyzed by SDS-PAGE and subsequent protein 
staining to identify complex partners (Haffner et al., 2004). A 130-kDa protein not present in 
control preparations was specifically enriched and identified by mass spectrometry as pM5, 
an uncharacterized protein which had been accidentally discovered in a screen for 
collagenase-related genes (Templeton et al., 1992). However, pM5 neither contains the 
conserved motif of all metalloproteases (HEXXH) nor does it show any other homology to 
collagenases. Based on functional data, indicating an involvement of pM5 in Nodal signaling 
(see section 1.2), it was given the name NOMO (Nodal mo
NOMO, like Nicalin a type-I transmembrane protein, has a large N-terminal domain (> 1,000 
amino acids) and also localizes to the ER, as demonstrated by deglycosylation experiments, 
immunfluorescence microscopy and subcellular fractionation (Haffner et al., 2007). The only 
motifs identified by bioinformatical analyses (PFAM domain search) were a coiled-coil 
domain and two Cna B domains (Fig. 8). The Cna B domain is found in the collagen binding 
surface protein of Staphylococcus aureus, but does not directly participate in collagen 
binding (Deivanayagam et al., 2000). It is also present in a high number (88 and 13 copies, 
respectively) in Colossin A and B, two huge proteins (~11 and 3.7 MDa) of unknown function 
encoded in the genome of the social amoeba Dictyostelium discoideum (Eichinger et al., 
2005).  
dulator) (Haffner et al., 2004).  
In the human genome, the nomo gene is one of three highly similar genes (nomo1, nomo2, 
nomo3) in a region of duplication located on the short arm of chromosome 16 (Loftus et al., 
1999; Martin et al., 2004). According to expression databases, all nomo genes are expressed 
and their transcripts are almost identical in sequence and length (Haffner et al., 2004; Fig. 8). 
Due to this similarity, the three nomo genes encode closely related proteins that are 
expected to have the same function. In this thesis, only NOMO2 was analyzed and referred 
to as NOMO. Two transcripts of nomo2 differing in one exon at their 3' ends and encoding 
different NOMO isoforms have been described. The shorter nomo2 transcript lacks a ~330-
bp exon, which would contain a stop codon, leading to an extended coding region and a 
NOMO2 variant with an elongated C-terminus. This long NOMO2 isoform (NOMO2-L) 
appears to be a rare variant, whereas the long nomo transcripts (leading to the shorter 
NOMO proteins) represent the common species (Haffner et al., 2004, Fig. 8). 
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1.2.2 Assembly of the Nicalin-NOMO complex 
First indications for a coordinate expression of Nicalin and NOMO came from RNA 
interference (RNAi) studies in HEK293T cells, where the knockdown of Nicalin led to a 
concomitant decrease of NOMO expression (Haffner et al., 2007), an effect reminiscent of 
the reduction of APH-1, PEN-2 and Presenilin expression in the absence of Nicastrin 
(Edbauer et al., 2002; Zhang et al., 2005). Likewise, a reduction of Nicalin expression was 
observed in NOMO knockdown cells, suggesting that both proteins, like γ-secretase 
components, are destabilized in the absence of complex formation. Quantitative mRNA 
measurements demonstrated that this destabilization takes place at the protein level. A 
further indication for the similarity with γ-secretase was the demonstration of Nicalin 
replacement: Nicalin overexpression resulted in a strong decrease of endogenous Nicalin 
protein, similar to a phenomenon observed for Presenilin (Thinakaran et al., 1997; see 
section 1.1.2). Furthermore, Nicalin overexpression in wild-type or Nicalin knockdown cells 
resulted in a strong increase in endogenous NOMO levels (Haffner et al., 2007), indicating 
that Nicalin might stabilize endogenous NOMO and thus elevate NOMO steady-state levels. 
In contrast, NOMO overexpression did not elevate Nicalin levels. Thus, a model was 
proposed in which NOMO is synthesized in excess amounts and stabilized by complex 
formation with Nicalin. Nicalin on the other hand has to be limited independently of NOMO. 
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TM 
 KKQKTRRT 
SP 
1 
  
 
Cna B 
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Cna B 
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aa identity to NOMO1: 1213 of 1222 aa ≙ 99.3 %  
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aa identity to NOMO1: 1214 of 1222 aa ≙ 99.3 %  
 
Fig. 8: NOMO protein and mRNA structure. A) Domain structure of NOMO. NOMO is a type-I transmembrane protein with a 
large N-terminal domain (> 1000 AS) facing the ER lumen, a transmembrane domain (TM, black), and a short cytosolic C-
terminus. Three N-glycosylation sites have been predicted (‘Y’). Identified domains include a coiled coil domain (light grey) and 
two Cna B domains (dark grey). The immature protein has a signal peptide (SP, underlined) for translocation into the ER. The 
longer isoform NOMO-L, generated by alternative splicing (see below), possesses an elongated C-terminus. B) The human 
genome contains three highly homologous nomo genes (adapted from Haffner et al., 2007). Schematic representation of 
nomo1, nomo2 and nomo3 mRNAs showing 5’-untranslated regions, coding regions (boxed) with the sizes of the encoded 
proteins in amino acids (aa) and stop codons, and 3’-untranslated regions. mRNA lengths in nucleotides (nt) and aa identity in 
comparison to NOMO1 are shown. Alternative splicing of the nomo2 transcript results in the deletion of the exon containing stop 
codon 1 and the generation of an mRNA with an extended reading frame encoding the long NOMO2 isoform NOMO-L.  
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1.3 Goals of this thesis 
The Nicalin-NOMO complex and γ-secretase are high-molecular-weight complexes that 
contain related molecules, Nicalin and Nicastrin, respectively. Both complexes are involved 
in important pathways during early embryonic development, the Nicalin-NOMO complex in 
the Nodal signaling pathway (reviewed by Haffner and Haass, 2004; Haffner and Haass, 
2006) and γ-secretase in the Notch signaling pathway (reviewed by Selkoe and Kopan, 
2003). Moreover, their expression levels are tightly controled by a post-transcriptional 
regulation mechanism which originates from the assembly of the complexes (Thinakaran et 
al., 1997; Edbauer et al., 2002; Lee et al., 2002; Zhang et al., 2005; Haffner et al., 2007).  
The native size of the Nicalin-NOMO complex, as determined by Blue-Native-PAGE, was 
shown to represent 200-220 kDa (Haffner et al., 2007), which is slightly smaller than the 
combined molecular weights of monomeric Nicalin (~60 kDa) and NOMO (~130 kDa). 
Therefore, the possibility was considered that the complex might contain unidentified 
components, likely in the low-molecular-weight range, similar to the γ-secretase factors APH-
1 and PEN-2. In the absence of animal models suited for genetic screens and the 
impracticality of other protein-protein interaction technologies (e.g. the yeast-two-hybrid 
system) for this goal, the advancement of the Nicalin affinity purification technique used to 
identify NOMO (Haffner et al., 2004) appeared to represent the most promising approach. In 
particular, the scale of the procedure was increased and the membrane protein lysis 
conditions were optimized.  
To rule out the missing of possible interactors because of too insensitive protein staining 
protocols, a proteomics approach was established in parallel. It included stable isotope 
labeling using amino acids in cell culture (SILAC) and subsequent mass spectrometry 
analysis of co-purified proteins allowing the identification of substoichiometric or transient 
binding partners. In addition to unidentified core complex components, this approach might 
yield functionally relevant transient interactors of Nicalin that could help to elucidate the 
molecular mechanism of the complex. The identification of such proteins could also help to 
shed light on the regulation and assembly mechanisms of membrane protein complexes in 
general.  
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2.  Results 
 
2.1  Transmembrane protein 147 co-purifies with the Nicalin-NOMO complex 
 
NOMO has been identified as Nicalin-binding protein by an affinity purification approach 
which included the preparation of cell membranes from HEK293 cells stably overexpressing 
myc-tagged Nicalin, the solubilization of the membranes using 3-[(3-cholamidopropyl) 
dimethylammonio]-1-propanesulfonate (CHAPS) as detergent, and the purification of Nicalin-
myc by anti-myc antibody-coupled agarose (Haffner et al., 2004). The Nicalin-NOMO 
membrane protein complex has a native size of 200-220 kDa, slightly larger than the 
combined molecular weights of its known components (Haffner et al., 2007). Therefore, the 
possibility was explored that the complex may contain unknown low-molecular-weight 
components which had been missed so far. The Nicalin affinity purification procedure was 
modified, most importantly by using higher amounts of membrane protein (up to 30 mg) and 
n-dodecyl-β-D-maltoside (DDM) instead of CHAPS as detergent. DDM has been used to 
purify γ-secretase (Winkler et al., 2009) and also allows the isolation of the Nicalin-NOMO 
complex. Coomassie Blue (Fig. 9) as well as silver staining (Fig. 11) methods were used to 
visualize potential Nicalin interacting proteins in SDS gels. Under these conditions, a 22-kDa 
band was specifically enriched in preparations from HEK293T/Ncl-myc cells (Fig. 9, middle 
panel) in addition to myc-tagged Nicalin (Ncl, ~60 kDa) and endogenous NOMO (~130 kDa).  
Fig. 9: TMEM147 was identified as Nicalin interacting protein by co-immunoprecipitation and mass spectrometry (LC-
MS/MS) analysis. Nicalin-myc (Ncl-myc; schematically illustrated on the left) was immunoprecipitated from large-scale membrane 
preparations (detergent: 0.7 % DDM) using an anti (α)-myc antibody. Bound proteins were visualized by Coomassie Blue staining 
(middle panel). In addition to NOMO (~130 kDa; schematically illustrated on the left), a ~22-kDa band was specifically enriched in 
precipitates from HEK293T/Ncl-myc cells (bands denoted with * represent immunoglobulin heavy and light chains; ‘e’: 
endogenous). LC-MS/MS analysis of tryptic peptides generated from this protein identified it as TMEM147 (Nifie14). Detected 
peptides of the human TMEM147 sequence (from four independent experiments) are highlighted in red (right panel); note that all 
peptides end with arginine (R) or lysine (K) residues as the R/K-specific protease trypsin was used for their generation. 
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This protein band was cut out from Coomassie Blue stained gels and subjected to in-gel 
trypsin digestion. Peptide mass fingerprints were generated by LC-MS/MS analysis and the 
results were analyzed by a MASCOT database search (see section 4.7). One protein 
repeatedly found among the most significant hits in several independent experiments was 
transmembrane protein 147 (TMEM147), an uncharacterized protein of 224 amino acids also 
known as Nifie14. However, most likely due to its hydrophobicity (see section 2.3) only six 
different peptides could be identified (Fig. 9, right panel) resulting in a sequence coverage of 
only 34.4 % and a relatively low score in the MASCOT analysis. Still, TMEM147 was 
considered the most promising candidate, as its calculated molecular weight of ~24 kDa fit 
well to the size of the isolated band and no other protein from the hit list showed a molecular 
weight in this range. Moreover, TMEM147 is similarly conserved as Nicalin and NOMO (see 
section 2.7). It is predicted to contain seven transmembrane domains (see section 2.3) and 
to largely reside within the membrane. Due to the lack of a significant homology to other 
proteins no function could be inferred from its sequence and no functional domains were 
identified. 
Since no anti-TMEM147 antibody was available, a monoclonal antibody (T147.11) was 
generated using a synthetic TMEM147 peptide as antigen (see section 4.5.1 and Fig. 31). Its 
specificity was demonstrated by several observations (Fig. 10): a) it recognizes a band of 
~22 kDa in HEK293T wild-type cells, in good agreement with the calculated mass of 
TMEM147, b) this band is strongly reduced in knockdown (KD) cells overexpressing 
TMEM147-specific shRNAs, and c) in cells overexpressing a V5-tagged TMEM147 version 
(rescue) a band of ~25 kDa is labeled.  
  
Fig. 10: The T147.11 antibody (AB) is specific for TMEM147 (T147). Immunoblot (IB) of membrane protein lysates from 
different HEK293T cells. A 22-kDa band is recognized in wild-type (wt) cells, which is reduced in TMEM147 knockdown (KD) cells. 
Reintroduction of an RNAi-insensitive V5-tagged construct (rescue cells) resulted in the labeling of a ~25-kDa band. 
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Using the T147.11 antibody, it could be shown that TMEM147 is indeed highly enriched in 
Nicalin immunoprecipitates (Fig. 11A, right panel). Unfortunately, like the Nicalin and NOMO 
antibodies, the T147.11 antibody did not work in co-immunoprecipitation assays. To 
nevertheless demonstrate the bidirectionality of the interaction between TMEM147 and 
Nicalin, the human TMEM147 cDNA was cloned from HEK293T cells, stably expressed in a 
V5-tagged version in HEK293T cells and TMEM147-V5 was precipitated from membrane 
protein lysates using an anti-V5-specific antibody. This specifically enriched proteins of ~60 
kDa and ~130 kDa, confirmed as Nicalin and NOMO by immunoblotting (Fig. 11B).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11: Co-precipitation between Nicalin, NOMO and TMEM147.  A) Nicalin-myc was immunoprecipitated from large-scale 
membrane preparations (detergent: 0.7 % DDM) and the bound proteins were visualized by silver staining (left panel). In 
addition to NOMO (~130 kDa), a ~22-kDa band, identified as TMEM147 (T147) by immunoblotting using the T147.11 antibody, 
was specifically enriched in precipitates from HEK293T/Ncl-myc cells. B) TMEM147-V5 was immunoprecipitated from large-
scale membrane preparations (detergent: 0.7 % DDM) and the bound proteins were visualized by Coomassie Blue staining (left 
panel). In addition to TMEM147-V5, a ~60 and a ~130-kDa band were specifically enriched (left panel) and identified as Nicalin 
and NOMO by immunoblotting (right panel). (bands denoted with * represent immunoglobulin heavy and light chains; ‘e’: 
endogenous) 
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Moreover, a strong enrichment of all three components was observed when the extent of co-
precipitation via TMEM147 (Fig. 12 A, middle lane) or Nicalin (Fig. 12 B, middle lane) was 
compared to input lysates (Fig. 12 A and B, respectively, left lanes). This indicated that the 
interaction between Nicalin, NOMO, and TMEM147 occurs in a roughly stoichiometric 
manner. Further support for this came from the analysis of the lysates after TMEM147 or 
Nicalin immunoprecipitation, where an efficient depletion of all three proteins could be 
demonstrated (Fig. 12 A and B, respectively, right lanes).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These data strongly suggested that the interaction of TMEM147 with the Nicalin-NOMO 
complex is highly specific and indicated that TMEM147 might indeed represent a novel 
component of the complex. 
 
 
 
  
Fig. 12: TMEM147 or Nicalin precipitation leads to the depletion of all complex members. Input, bound (IP) and unbound 
(post-IP) material of TMEM147-V5 (A), and Nicalin-myc (B) immunoprecipitations were compared by immunoblotting. A strong 
enrichment of all three binding partners in TMEM147 or Nicalin-precipitates (middle lanes) as well as their depletion in the post-IP 
supernatants (right lanes) was observed. No significant binding or depletion of the ER membrane protein Calnexin was 
detectable. (‘e’: endogenous) 
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Fig. 13: Nicalin and NOMO, but not TMEM147, contain N-linked, high-mannose carbohydrates. HEK293T/T147-V5 cell 
lysates were treated with N-glycosidase F or endoglycosidase H and submitted to SDS-PAGE and immunoblotting. Both 
treatments resulted in a slight reduction in the molecular weights of Nicalin and NOMO, demonstrating the presence of high- 
mannose carbohydrates, while TMEM147 molecular weight was not changed, in agreement with the lack of N-glycosylation 
consensus sequences. 
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2.2  TMEM147 co-localizes with Nicalin and NOMO in the ER 
 
Nicalin and NOMO have been shown to localize to the ER by various approaches including 
the analysis of their N-glycosylation status (Haffner et al., 2004, 2007). Many proteins of the 
secretory pathway receive N-linked carbohydrates during their translocation into the ER 
lumen (Helenius and Aebi, 2002). Preassembled sugar chains rich in mannose are attached 
to asparagine (N) residues residing within a certain amino acid motif (N-X-S/T, i.e. 
asparagine - any amino acid - serine/threonine). The carbohydrates of proteins destined for 
the late secretory pathway usually undergo stepwise modifications in the Golgi apparatus 
including removal of the majority of the mannose molecules and the addition of various other 
sugars. This results in the generation of complex carbohydrates, whereas glycoproteins 
restricted to the early secretory pathway (predominantly ER) keep their high-mannose 
sugars. These two types of N-linked carbohydrates can be experimentally distinguished by 
using sugar-cleaving enzymes and subsequently determining the molecular weight of the 
deglycosylated protein. Whereas this analysis confirmed the previously reported (Haffner et 
al., 2007) presence of high-mannose sugars on Nicalin and NOMO, no molecular weight shift 
was detected for TMEM147 (Fig. 13), in agreement with the absence of N-glycosylation 
motifs within the TMEM147 sequence (see also Fig. 18). As a consequence, this approach 
was not suitable to analyze the subcellular localization of TMEM147. 
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Fig. 14: TMEM147 and Nicalin co-localize within the ER. Immunofluorescence microscopy pictures of wild-type HeLa cells 
(top panel) and HeLa cells overexpressing V5-tagged TMEM147 (bottom panel). Nicalin co-localizes with the ER-marker 
Calnexin (top panel), confirming the ER-localization of endogenous Nicalin. The overlap between the TMEM147-V5 and the 
Nicalin staining (bottom panel) is similarly good demonstrating co-localization within the ER.  
As an alternative method to analyze the subcellular localization of TMEM147, 
immunofluorescence microscopy was used. For overexpressed Nicalin and NOMO, an ER-
like staining pattern has been demonstrated in HEK293 cells (Haffner et al., 2004) by this 
approach. In this thesis, the newly generated anti-Nicalin (NiNT1), anti-NOMO (NOM4A12), 
and anti-TMEM147 (T147.11) antibodies (see section 4.5.1) were tested in 
immunofluorescence experiments for their ability to detect their endogenous target proteins 
in human cervix carcinoma HeLa cells. Whereas staining with NiNT1 yielded a pattern very 
similar to that of the ER-marker Calnexin confirming the ER-localization of Nicalin (Fig. 14, 
top panel), endogenous NOMO and TMEM147 levels were under the detection limit of their 
antibodies. Therefore, TMEM147 localization had to be analyzed in cells stably 
overexpressing TMEM147-V5. A co-staining with NiNT1 and an anti-V5 epitope antibody 
showed a high degree of overlap, suggesting co-localization of Nicalin and TMEM147 (Fig. 
14, bottom panel) in the ER.  
 
 
 
 
To confirm the immunoflurescence microscopy results by an independent approach and to 
analyze the subcellular localization of endogenous TMEM147, separation of cellular 
membranes by density gradient centrifugation and analysis of the obtained fractions by SDS-
PAGE/immunoblotting was used. In iodixanol gradients, the buoyant density of subcellular 
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membranes increases in the following order: plasma membrane < early endosomes < Golgi 
< ER Golgi-intermediate compartment (ERGIC) < ER. As a consequence, ER membranes 
were found in the bottom four fractions (demonstrated by the presence of Calnexin and 
Nicastrin containing immature N-linked carbohydrates) when HEK293T membranes were 
subjected to ultracentrifugation in an iodixanol gradient (Fig. 15). The other fractions 
contained proteins of the later secretory pathway (e.g. Golgi) and the plasma membrane, as 
demonstrated by the presence of the complex glycosylated form of Nicastrin. Like Nicalin 
and NOMO, TMEM147 immunoreactivities could only be detected in these four fractions, 
suggesting that indeed none of the complex components leaves the early compartments of 
the secretory pathway.  
  
 
 
 
 
 
 
 
Taken together, these data demonstrated that TMEM147 co-localizes with Nicalin and 
NOMO in the ER further supporting the idea that TMEM147 is a genuine part of the complex.
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Fig. 15: TMEM147, Nicalin and NOMO cofractionate with ER membranes.  Membrane protein lysates from HEK293T cells 
were subjected to ultracentrifugation in an iodixanol gradient. Fractions were collected and subsequently analyzed by 
immunoblotting. Nicalin and NOMO were detected in the four bottom fractions enriched in ER membranes, as shown by the 
presence of the ER-marker Calnexin, the presence of immature (‘i’) and the absence of mature (‘m’) Nicastrin (fraction 4 also 
contained material from the early Golgi compartment, where the maturation of Nicastrin’s N-linked carbohydrates occurs). 
Apparently, protein concentration in fraction 3 was lower than in other fractions.   
 
  Results 
 
27 
    
    
  
  
        
        
CD4 
CD4-NclC 
CD4 
Calnexin 
Calnexin 
CD4 
HeLa cells + CD4-NclC 
HeLa cells + CD4 
    
    
  
  
        
        
10 µm 
10 µm 
merge 
merge 
The ER-localization of proteins is usually mediated by certain amino-acid motifs that actively 
promote their retention and/or retrieval. As the C-terminal motif in the cytosolic tail of Nicalin 
(...KAKTQ-COOH) resembles the classical KKXX-motif mediating the retrieval of 
transmembrane proteins to the ER (Nilsson et al., 1989; Jackson et al., 1990), it was tested 
whether it can function as an ER-localization signal. For that purpose, the Nicalin C-terminal 
sequence (YKTVQRLLVKAKTQ) was fused to the ectodomain and transmembrane domain 
of the cell surface protein CD4 (cluster of differentiation 4), which like Nicalin is a type-I 
transmembrane protein and had been used to analyze motifs in the C-termini of Nicastrin 
(Capell et al., 2005) and Presenilin (Kaether et al., 2004). The subcellular localization of this 
chimeric protein (CD4-NclC) was analyzed by immunofluorescence microscopy in 
transfected HeLa cells. Whereas for wild-type CD4 the expected surface-like staining was 
observed, the CD4-NclC chimera co-localized with Calnexin in the ER (Fig. 16) suggesting 
that the Nicalin C-terminus contains an ER-localization signal. However, a Nicalin deletion 
mutant lacking the cytosolic C-terminus (NicalinΔC, see section 2.6) still localized mainly in 
the ER indicating that the exact mode of ER retention/retrieval of the complex might be more 
complicated. Thus, this question requires further investigation. 
 
 
 
 
Fig. 16: The Nicalin C-terminus contains an ER-localization signal. The presumptive cytosolic C-terminus of Nicalin, 
YKTVQRLLVKAKTQ, was fused to the ectodomain and transmembrane domain of the cell surface protein cluster of differentiation 
4 (CD4). The localization of the resulting chimeric protein CD4-Nicalin C-terminus (CD4-NclC, top panel) and of wild-type CD4 
(bottom panel) were analyzed by immunofluorescence microscopy in transfected HeLa cells. As expected, the expession of wild-
type CD4 only slightly overlapped with the ER-marker Calnexin, while most of the protein was found in a plasma membrane-like 
staining (red areas in the bottom ‘merge’ picture). In contrast, the chimeric CD4-NclC co-localized with the ER-marker Calnexin. 
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2.3 The TMEM147 topology is similar to APH-1 
Human TMEM147 consists of 224 amino acids (aa), with a high percentage of hydrophobic 
residues like leucine (12.5 % of all aa), alanine (10.7 %) or valine (9.5 %). Thus, size and 
hydrophobicity of TMEM147 were reminiscent of the γ-secretase component APH-1, which 
consists of 247 aa in its short isoform APH-1aS and contains 12.5 % leucine, 10.9 % alanine 
and 9.7 % valine residues. However, global (Needleman and Wunsch, 1970) and local 
(Smith and Waterman, 1981) alignment by the EMBOSS program did not reveal an obvious 
homology between the two proteins. Nevertheless, the possibility that TMEM147 and APH-1 
might share some structural similarities was further analyzed by comparing Kyte-Doolittle 
hydrophobicity plots using the Protscale tool (Fig. 17). For the short isoform APH-1aS seven 
transmembrane (TM) domains were predicted, in agreement with experimental data (Fortna 
et al., 2004). The plot for TMEM147 showed six to seven putative TM domains suggesting 
that its overall structure may be very similar to the polytopic γ-secretase component, except 
for a more prominent loop between TM domains three and four and a larger N-terminus in 
APH-1aS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To confirm the putative TMEM147 topology especially at the C-terminus, a hidden Markov 
model (PRODIV-TMHMM; Viklund and Elofsson, 2004) was applied as an alternative 
prediction method. As for APH-1aS, the program calculated seven TM helices for TMEM147 
(Fig. 18). 
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Fig. 17: Kyte-Dolittle plot of APH1-aS and TMEM147. The hydrophobicity was plotted using the Protscale tool by the Kyte-
Doolittle method with a seven amino-acid window. A positive value is indicative of a transmembrane region, a negative value of 
a loop region. A gap was introduced into the TMEM147 plot to align transmembrane domains 4-7.  
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Fig. 18: TMEM147 is a seven transmembrane protein. Approximate localization of TM domains in TMEM147, as predicted by 
the PRODIV-TMHMM algorithm (Viklund and Elofsson, 2004) as a part of the TOPCONS server. 
 
Moreover, the orientation of the TM domains within the membrane was predicted to be 
identical between the two proteins, with the odd-numbered loops and the C-termini facing the 
cytosolic side and the even-numbered loops and the N-termini facing the luminal side. A 
signal peptide was predicted for neither protein. The result of this analysis is illustrated in Fig. 
19. 
 
 
 
 
 
 
 
 
 
Fig. 19: TMEM147 topology is similar to APH-1aS. Comparison of topology models of human TMEM147 and human APH-
1aS generated by the PRODIV-TMHMM method (Viklund and Elofsson, 2004) as a part of the TOPCONS server. The topology 
of APH-1 has been experimentally validated (Fortna et al., 2004) and the prediction for TMEM147 is highly similar: seven 
transmembrane helices, with the N-terminus residing in the ER lumen and the C-terminus facing the cytosol. Thus, the 
localization of the hydrophilic loops of both proteins would be identical and even their lengths similar in most cases. 
Transmembrane domains are numbered (white numbers) and predicted loop sizes are reflected. 
 
 
However, the reliability of the bioinformatical tools used is limited and additional biochemical 
analyses will be necessary to validate the topology of TMEM147.  
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2.4  TMEM147, Nicalin, and NOMO stabilize each other 
 
Although the precise function of APH-1 within γ-secretase is not known, it is required for the 
maintenance of the steady-state levels of the complex, which is based on the mutual 
stabilization of the individual components upon incorporation into the complex (Gu et al., 
2003). One consequence of this stabilization mechanism is the so-called replacement, the 
reduction of the expression levels of endogenous APH-1 upon overexpression of ectopic 
APH-1. It is explained by the incorporation of ectopically expressed APH-1 monomers at the 
expense of endogenous molecules, which are likely to be degraded (although this 
degradation could never be formally demonstrated). Experimentally, this replacement can be 
analyzed by the overexpression of epitope-tagged protein versions which are separated from 
the endogenous proteins by their higher molecular weight. This phenomenon has not only 
been observed for the γ-secretase components APH-1 and Presenilin 1/2 (Thinakaran et al., 
1997), but also for Nicalin. Stable overexpression of Nicalin fused to a myc/His-tag results in 
a strong reduction of endogenous Nicalin in HEK293T cells (Fig. 20A; Haffner et al., 2007). 
Thus, the replacement of endogenous proteins by their exogenously expressed counterparts 
appears to be a characteristic feature of both γ-secretase and the Nicalin-NOMO complex 
(NOMO replacement could not be shown so far, since the separation of wild-type and tagged 
protein is difficult in the high-molecular weight range). To examine if TMEM147 is subjected 
to this replacement, the effect of stable TMEM147-V5 overexpression in HEK293T cells was 
analyzed by immunoblotting. Strikingly, the endogenous protein was reduced below the 
detection limit of the T147.11 antibody (Fig. 20B) suggesting that TMEM147, like Nicalin, is 
controled by complex formation.  
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Fig. 20: Nicalin or TMEM147 overexpression leads to the replacement of the respective endogenous proteins. A) Myc-
tagged Nicalin stably expressed in HEK293T cells (293T-Ncl) causes a strong reduction of the endogenous protein, which is 
present in wild-type HEK293T cells (293T). B) Similarly, stable TMEM147-V5 overexpression in HEK293T cells (293T-T147) 
leads to the replacement of endogenous TMEM147. Membrane proteins lysates were analyzed by SDS-PAGE and 
immunoblotting using specific antibodies. 
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A second consequence of the described stabilization mechanism is the instability of some (or 
all) complex components in the absence of one of their interaction partners. This has been 
shown, either in knockout cells or by RNA interference (RNAi), for the γ-secretase 
components Nicastrin (Edbauer et al., 2002), Presenilin (Leem et al., 2002; Edbauer et al., 
2002;), APH-1 (Francis et al., 2002), and PEN-2 (Steiner et al., 2002). A similar effect has 
been observed for Nicalin and NOMO: The downregulation of Nicalin or NOMO expression 
by RNAi in HEK293T cells resulted in the reduction of the steady-state levels of the 
respective binding partner demonstrating a mutual dependence similar to γ-secretase 
components (Haffner et al., 2007; see Fig. 22A, B). Due to the long half-life of Nicalin and 
NOMO, the standard RNAi technique - transient transfection of siRNAs (small interfering 
RNAs) - was not applicable for their downregulation. Instead, stable expression of constructs 
encoding small hairpin RNAs (shRNAs, precursor molecules that are processed to siRNAs 
by the cellular machinery) was required to achieve efficient knockdowns (Haffner et al., 
2007). However, this technique has some drawbacks: The selection of single-cell clones is 
time-consuming, involves the risk that the genetic/epigenetic background of the clone biases 
subsequent analyses, and does not allow analyzing the effects of acute protein depletion. 
Moreover, this technique is only suitable for cell lines that can be readily transfected with the 
existing reagents and are able to form single-cell clones. Therefore, an alternative method for 
the generation of stable Nicalin, NOMO, and TMEM147 knockdown cell lines was developed 
(1) to analyze the universality of the effects of Nicalin and NOMO downregulation and (2) to 
examine the consequences of TMEM147 depletion. This method was based on a lentivirus 
system which has been successfully used for a variety of targets (Wiznerowicz and Trono, 
2003). Shortly, this approach uses a lentivirus-derived vector, which carries shRNA-coding 
sequences. The important regions of this vector are packaged into infective lentiviral particles 
by a packaging cell line. The supernatant of this cell line contains the infective particles and 
can be used to transduce target cells. Upon transduction, the vector regions are stably 
integrated into the genome and shRNAs are produced (for more details, see sections 4.3.1, 
4.4.1, 4.4.5). In principle, a transduction efficiency of nearly 100 % can be achieved for all 
possible cells, and stable cell pools can be obtained within days and immediately be 
analyzed. 
To test the lentiviral knockdown approach, HeLa instead of HEK293T cells were selected, 
which are similarly proliferative and as easy to handle as HEK293T cells, but due to their 
spread out morphology are superior to HEK293T cells in microscopy experiments. Thus, 
HeLa knockdown cells might become useful tools for microscopy-based assays in the future. 
In cell pools stably expressing Nicalin-, NOMO- or TMEM147-specific shRNAs knockdown 
efficiencies between 70 % and 90 % were reached, as quantitated on the mRNA level by 
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real-time PCR (Fig. 21B). In Nicalin- and NOMO-depleted cells, the mutual dependence of 
the expression levels of these two proteins reported in HEK293T cells (Haffner et al., 2007) 
could be confirmed (Fig. 21A, third and fourth lane). Strikingly, a strong reduction of 
TMEM147 expression was observed in both cell lines. Moreover, the knockdown of 
TMEM147 led to a similar reduction of Nicalin and NOMO (Fig. 21A, fifth lane) showing that 
TMEM147 is subjected to the same stabilization mechanism. To demonstrate the reversibility 
of this effect, the TMEM147 knockdown in HeLa cells was rescued by the expression of a 
V5-tagged version migrating at ~25 kDa (Fig. 21A, sixth lane). The TMEM147 rescue 
construct contained silent mutations at the siRNA targeting site conferring siRNA-resistance 
and was, like the shRNA constructs, transduced using a lentiviral system (see sections 4.3.1, 
4.4.1 and 4.4.5). The rescue led to the restoration of Nicalin and NOMO levels and to the 
replacement of the residual endogenous TMEM147. An effect on the transcriptional level 
could be ruled out as the mRNAs of the respective non-targeted complex partners were not 
significantly changed, demonstrated by quantitative real-time PCR (Fig. 21B). 
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Fig. 21: Mutual dependence of Nicalin, NOMO and TMEM147 protein levels in HeLa cells. A) Stable Nicalin, NOMO, and 
TMEM147 knockdown (KD) cell lines were generated by transducing HeLa cells with lentiviruses encoding the respective 
shRNAs. Protein expression levels were detected by immunoblotting. Upon knockdown of either Nicalin, NOMO or TMEM147, a 
strong reduction of the respective binding partners was observed. Stable reintroduction of an RNAi-resistant TMEM147-V5 
cDNA into T147 KD cells (T147 rescue) restored NOMO and Nicalin levels. B) mRNA levels in HeLa knockdown cells were 
analyzed by quantitative real-time PCR. Target gene expression was found to be decreased by 75-90%, while mRNA levels of 
the interaction partners were only marginally changed. Bars represent mean values from three experiments. 
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Fig. 22: Mutual dependence of Nicalin, NOMO, and TMEM147 protein levels in HEK293T cells. A) TMEM147 and Nicalin 
expression are reduced in NOMO knockdown (KD) cells and restored in NOMO rescue cells, i.e. KD cell lines stably expressing 
RNAi-insensitive nomo mRNA. B) TMEM147 and NOMO expression is reduced in Nicalin KD cells and restored in Nicalin rescue 
cells. In a high expression Ncl rescue clone (Ncl resc9), NOMO and TMEM147 expression are not only restored, but drastically 
increased. C) The strong increase in TMEM147 and NOMO in Ncl resc9 is accompanied by increased complex formation 
compared to resc1, demonstrated by a high extent of co-immunoprecipitation via Nicalin. D) The strong increase in TMEM147 
and NOMO in Ncl resc9 cells is not accompanied by increased expression of tmem147 and nomo mRNA as analyzed by 
quantitative real-time PCR (bars represent mean values from three experiments). Only nicalin mRNA is significantly higher in the 
resc9 cells (~13-fold). 
TMEM147 expression was also examined in the HEK293T Nicalin and NOMO rescue cell 
lines previously described (Haffner et al., 2007). The restoration of Nicalin and NOMO 
expression in these cell lines also resulted in a restoration of TMEM147 levels (Fig. 22A, B) 
strongly suggesting that the observed effects are specific. However, differences in the 
NOMO and Nicalin rescue cell lines became obvious: The stable expression of high levels of 
NOMO cDNA in NOMO KD cells restored Nicalin and TMEM147 expression levels to wt 
levels, but not higher (Fig. 22A). In strong contrast, a dose-dependent effect was observed in 
Nicalin rescue cells: The expression of roughly wild-type levels of Nicalin in a low-expressing 
Nicalin rescue clone (Fig. 22B, resc1) restored NOMO and TMEM147 back to roughly wild-
type levels, while in a high-expressing Nicalin rescue clone (Fig. 22B, resc9) TMEM147 as 
well as NOMO expression exceeded wild-type levels severalfold. These results corroborated 
the hypothesis proposed previously that Nicalin might represent the master regulator of the 
complex (Haffner et al., 2007). 
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Co-immunoprecipitation showed that the elevation of TMEM147 and NOMO in the high-
expressing Nicalin resc9 clone is accompanied by increased complex formation compared to 
the low expressing resc1 clone (Fig. 22C). Quantitative mRNA measurements ruled out 
effects on the transcriptional level: In the high-expressing resc9 clone only nicalin mRNA 
levels were higher than in resc1 (more than ten-fold), while nomo and tmem147 mRNA levels 
were similar (Fig. 22D).  
To verify the results obtained in rescue cell lines suggesting Nicalin to represent the key 
regulator of the complex, overexpression experiments were repeated in HEK293T wild-type 
cells. Cell lines stably expressing Nicalin, NOMO, and TMEM147 cDNAs were analyzed by 
immunoblotting. Like in the rescue experiments, an elevation of TMEM147 and NOMO was 
observed upon Nicalin overexpression (Fig. 23, third lane). TMEM147 as well as NOMO 
overexpression, either alone or in combination, did not result in elevated Nicalin levels (Fig. 
23, second, fifth and sixth lane), further confirming the data from the rescue experiments and 
underlining that Nicalin plays a special role in the regulation of the complex.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In summary, the observed effects on Nicalin and NOMO upon TMEM147 downregulation as 
well as the changes in TMEM147 expression in response to Nicalin and NOMO depletion 
strongly suggest that TMEM147 is indeed a core component of the Nicalin-NOMO complex. 
Moreover, the key role of Nicalin in controling complex levels proposed previously was 
corroborated as was the posttranscriptional nature of the effects.  
  
Fig. 23: Nicalin overexpression increases NOMO and TMEM147 levels, but not vice versa. Stable Nicalin, NOMO, and 
TMEM147 expression in HEK293T cells. NOMO overexpression has no effect on Nicalin or TMEM147 protein levels, whereas 
Nicalin overexpression leads to an increase in NOMO and TMEM147 expression. TMEM147 overexpression does not alter 
Nicalin or NOMO, but results in a decrease of endogenous TMEM147 below the detection limit of the T147.11 antibody 
(replacement; see Fig. 20). Even when TMEM147 and NOMO are simultaneously overexpressed Nicalin expression is not 
elevated. Controls are Calnexin (left half) and ß-Actin (right half).  
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2.5  Nicalin controls complex levels by stabilizing excess molecules 
 
Quantitave mRNA measurements (see Fig. 22D) had ruled out the possibility that the 
elevated expression of TMEM147 and NOMO upon Nicalin overexpression is due to 
enhanced transcription of tmem147 and nomo mRNA. Moreover, co-immunoprecipitation 
analyses demonstrated that the elevation of NOMO and TMEM147 in Nicalin overexpressing 
cells is accompanied by enhanced complex formation suggesting a protein stabilization 
mechanism similar to that proposed for γ-secretase. If this hypothesis was true, an unstable 
and rapidly degraded NOMO and TMEM147 pool would be expected in wild-type cells. 
However, when the cellular protein synthesis was blocked for 6 hours by inhibiting the 
ribosome using the drug cycloheximide, the levels of all three components were not visibly 
changed (Fig. 24, middle lane). This finding indicated that under steady-state conditions most 
NOMO and TMEM147 molecules are like Nicalin present in a stable complex, while their 
unstable counterparts had to be extremely short-lived. To test this idea, the cellular 
proteasomes (one possible degradation machinery of unstable proteins) of HEK293T cells 
were blocked for six hours by the drug epoxomicine. Immunoblotting showed that this 
treatment led to an accumulation of TMEM147 and NOMO, but not Nicalin, compared to 
untreated cells (Fig. 24, right lane). These findings corroborated a model in which a) 
TMEM147 and NOMO are present in an unstable excess under steady-state conditions, b) 
Nicalin is not present in an excess but rather the limiting factor of the complex, and c) 
proteasomal pathways at least contribute to the degradation of NOMO and TMEM147 
excess molecules. Thus, the elevation of NOMO and TMEM147 upon Nicalin expression can 
be considered a protein stabilization phenomenon. 
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Fig. 24: TMEM147 and NOMO, but not Nicalin, are synthesized in an excess which is unstable in wild-type cells. Nicalin, 
NOMO and TMEM147 immunoreactivities were not visibly changed upon ribosome inhibition (chx.: cycloheximide, 6 hours) 
compared to untreated cells (left lane), which indicated a long half-life under steady-state conditions. Proteasome inhibition 
(epox.: epoxomicin, 6 hours) resulted in an increase in ß-Catenin as well as NOMO, and TMEM147 protein levels. This indicated 
the synthesis of excessive NOMO and TMEM147, but not Nicalin molecules.  
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The kinetics of the NOMO stabilization through Nicalin had been previously analyzed by 
using a cell line in which Nicalin expression can be induced by tetracycline (Haffner et al., 
2007). In these cells, an immediate expression of high levels of Nicalin can be achieved by 
tetracycline treatment causing a continuous increase in NOMO protein levels over time, until 
NOMO has finally adapted to Nicalin levels later than 24 hours after Nicalin induction. The 
analysis of endogenous TMEM147 levels in these cells by immunoblotting revealed an 
increase with similar, but not identical kinetics (Fig. 25). Both NOMO and TMEM147 were 
highly increased 48 hours after Nicalin induction, but the increase in TMEM147 expression 
appeared to lag behind that of NOMO. NOMO levels were strongly increased already 24 
hours after Nicalin induction and did not rise much further during the next 24 hours of 
tetracycline treatment. In contrast, only a slight increase in TMEM147 could be observed 
after 24 hours and most of the stabilization of TMEM147 took place between 24 and 48 
hours after Nicalin induction. Nevertheless, both NOMO and TMEM147 elevation were 
accompanied by higher amounts bound to Nicalin, as shown by co-immunoprecipitation 
confirming that increased complex formation occurs. The difference in the kinetics of 
TMEM147 and NOMO stabilization might indicate that its assembly occurs in a stepwise 
manner (see sections 2.7 and 3.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig. 25: Nicalin induction leads to a continuous stabilization of TMEM147 and NOMO excess molecules in the complex. 
Kinetics of NOMO and TMEM147 stabilization and complex formation were analyzed in cells with inducible Nicalin expression 
(293TR/Ncl). Expression of myc-tagged Nicalin was induced by tetracycline for the indicated times, and Nicalin, NOMO and 
TMEM147 levels in lysates and Nicalin immunoprecipitates were analyzed by immunoblotting. A continuous increase in 
TMEM147 and NOMO expression over time was observed in lysates (four left lanes), which was accompanied by enhanced co-
immunoprecipitation (four right lanes). The elevation of NOMO appears to precede that of TMEM147. 
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2.6  TMEM147 and NOMO differ in their Nicalin binding requirements 
 
The difference in the stabilization kinetics of TMEM147 and NOMO upon Nicalin induction 
(Fig. 25) indicated the possibility of distinct subcomplexes during the formation of the Nicalin-
NOMO complex. In the case of γ-secretase assembly, intermediates like Nicastrin/APH-1 
have been identified by using increasing concentrations of the detergent DDM for the 
solubilization of membrane proteins (Fraering et al., 2004). Therefore, a similar approach 
was applied to search for intermediates of the Nicalin-NOMO complex. A double stable cell 
line expressing both Nicalin-myc and TMEM147-V5 was generated and membrane protein 
lysates prepared under varying detergent conditions were subjected to co-
immunoprecipitation studies using epitope tag-specific antibodies. The use of up to 2.5 % of 
DDM did not lead to clear results (data not shown), but in lysates containing 1 % Nonidet P-
40 (NP-40), NOMO but not TMEM147, could be co-precipitated with Nicalin (Fig. 26, fourth 
lane). In agreement with this, TMEM147 immunoprecipitation from NP-40-containing lysates 
revealed no co-precipitation of Nicalin or NOMO (Fig. 26, sixth lane). In contrast, all three 
proteins could be detected in immunoprecipitates containing DDM (Fig. 26, third and fifth 
lane). These data supported the idea of a stable Nicalin/NOMO subcomplex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig. 26: TMEM147 is dispensible for Nicalin-NOMO interaction. Nonidet P-40 (NP-40) partially disrupts the complex, allowing 
the isolation of a subcomplex consisting of only Nicalin and NOMO. Membrane protein lysates containing either 0.7 % DDM or 1 
% NP-40 were generated from 293T/TMEM147-V5/Nicalin-myc cells. Using NP-40 lysates, neither NOMO nor Nicalin could be 
detected in TMEM147 immunoprecipitates (right lane), but a Nicalin/NOMO subcomplex could be isolated by precipitating Nicalin 
(fourth lane). From DDM lysates, NOMO and TMEM147 (both V5-tagged and endogenous) were precipitated via Nicalin (third 
lane) and Nicalin and NOMO were precipitated via TMEM147 (fifth lane). 
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Interestingly, the detergent NP-40 is known to completely disrupt γ-secretase, a protein 
complex where the components are believed to interact mainly via transmembrane domains 
(LaVoie et al., 2003). Thus, the removal of TMEM147 from the Nicalin-NOMO complex in the 
presence of NP-40 suggested a similar type of interaction, in agreement with the predicted 
localization of the majority of the protein within the membrane (see Fig. 18-20). In contrast, 
the stability of a Nicalin/NOMO subcomplex in the presence of NP-40 raised the idea that 
their association might be mediated by their luminal domains. To determine the Nicalin 
domains required for the interaction with NOMO and TMEM147, Nicalin deletion constructs 
were generated, stably expressed in HEK293T cells, and their abilities to stabilize NOMO 
and TMEM147 levels were analyzed as an indirect measure for binding. The expression of 
myc-tagged Nicalin lacking the 14 amino acids of the predicted cytosolic C-terminus 
(NicalinΔC-myc) resulted in an increase in both NOMO and TMEM147 protein levels to a 
similar extent (Fig. 27), although less efficiently than the expression of myc-tagged full-length 
Nicalin (Nicalin-myc). In contrast, Nicalin lacking both cytosolic C-terminus and the 24 amino 
acids of the predicted Nicalin transmembrane domain (NicalinΔTMC, the Nicalin ectodomain) 
only stabilized NOMO leaving TMEM147 expression levels unchanged (Fig. 27). These 
findings supported the hypothesis that the Nicalin transmembrane domain is essential for 
TMEM147 but dispensable for NOMO interaction. 
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Fig. 27: The Nicalin transmembrane domain is essential for TMEM147, but dispensable for NOMO binding (I). Nicalin-
myc and the deletion mutants NicalinΔC-myc and NicalinΔTMC (see schematic illustration on the right) were stably expressed in 
HEK293T cells. Effects on NOMO and TMEM147 levels were analyzed by immunoblotting (in comparison to wild-type and 
NOMO expressing cells). Whereas NicalinΔC-myc elevated both NOMO and TMEM147 (although less efficiently than Nicalin-
myc), only NOMO was increased in NicalinΔTMC expressing cells. Below, the C-terminal 63 amino acids of Nicalin are shown 
with the predicted transmembrane domain highlighted in black. 
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As an alternative, independent approach for the functional analysis of the Nicalin deletion 
mutants, a knockdown rescue experiment was carried out (Fig. 28). RNAi-insensitive cDNAs 
coding for Nicalin-myc, NicalinΔC (without myc-tag), and NicalinΔTMC were stably 
introduced into Nicalin knockdown (Ncl KD) HEK293T cells to generate rescue cell lines (Ncl 
KD rescue). In a cell clone expressing high levels of NicalinΔC (untagged), NOMO and 
TMEM147 expression were restored to a similar extent above wild-type levels, although less 
efficiently than upon expression of full-length Nicalin-myc. In contrast, only low expressing 
clones were identified among the NicalinΔTMC rescue cells and in those NOMO expression 
was restored to roughly wild-type levels, while TMEM147 expression was still as low as in 
Nicalin knockdown cells. This confirmed the observations from the overexpression studies in 
wild-type cells and supported the hypothesis that Nicalin interacts with TMEM147 via 
Nicalin’s transmembrane domain whereas the interaction with NOMO is mediated by 
Nicalin’s luminal domain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To demonstrate the inability of NicalinΔTMC to interact with TMEM147 more directly, co-
immunoprecipitation experiments were carried out. Since the anti-Nicalin antibody NiNT1 is 
not suitable for immunoprecipitation and untagged NicalinΔTMC could therefore not be 
specifically enriched, NicalinΔTMC was co-expressed in a stable cell line together with myc-
tagged NOMO and V5-tagged TMEM147. Lysates from this triple-transfected cell line were 
used for co-immunoprecipitation analyses using epitope tag-specific antibodies. When 
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Fig. 28: The Nicalin transmembrane domain is essential for TMEM147, but dispensable for NOMO binding (II). RNAi-
insensitive Nicalin-myc, NicalinΔC and NicalinΔTMC constructs (see schematic illustration on the right) were stably expressed in 
HEK293T/Nicalin knockdown (Ncl KD) cells, generating the respective rescue cell lines. The ability of the deletion mutants to 
restore NOMO and/or TMEM147 protein levels was analyzed by immunoblotting (compared to wild-type and Ncl KD cells). 
NicalinΔC was able to rescue both NOMO and TMEM147 expression (although the elevation of protein levels beyond wild-type 
levels was less efficient compared to Nicalin-myc). In contrast, NicalinΔTMC was unable to restore TMEM147 expression, but 
restored NOMO to wild-type levels. 
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NOMO was immunoprecipitated (using an anti-myc antibody), large amounts of NicalinΔTMC 
were co-isolated, whereas no enrichment of TMEM147 was observed (Fig. 29, third lane). 
Upon TMEM147 precipitation (via an anti-V5 antibody), only minor amounts of a protein with 
a migration behaviour identical to endogenous Nicalin (which is not replaced by NicalinΔTMC 
in these cells) were observed (Fig, 29, fourth lane). This suggested that TMEM147 
selectively binds to full-length Nicalin and no significant interaction with NicalinΔTMC occurs, 
further supporting the idea that the Nicalin TM domain is essential for TMEM147 interaction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The findings presented in this section led to a model of a hierarchical complex assembly, 
which is discussed in section 3.2.  
 
 
2.7    The interaction of TMEM147 with Nicalin/NOMO is evolutionary conserved 
 
Nicalin and NOMO orthologs have been reported to be present in all multicellular organisms 
(Haffner et al., 2004). Similarly, expression databases like Uniprot indicated the presence of 
TMEM147 orthologs in all metazoans. Fig. 30 shows the degree of amino-acid identity 
(generated by FASTA alignment) between the human Nicalin, NOMO, and TMEM147 
proteins and the respective orthologs from common model organisms ranging from 
Arabidopsis thaliana to mouse. All three proteins are conserved to a similar extent among 
Fig. 29: NOMO, but not TMEM147, physically interacts with the Nicalin ectodomain NicalinΔTMC. Membrane protein 
lysates were prepared from a HEK293T cell line stably expressing V5-tagged TMEM147, myc-tagged NOMO and untagged 
NicalinΔTMC (see illustration on the right) and subjected to tag-specific immunoprecipitation. Precipitates were analyzed by 
immunoblotting (left panel, right two lanes). For comparison, input lysates and lysates from wild cells are shown (left two lanes). 
NicalinΔTMC could be precipitated in large quantities via NOMO. Only minor amounts of Nicalin were found in TMEM147 
precipitates and the running behavior in an SDS-PAGE identified this Nicalin species as endogenous full-length Nicalin (which is 
not replaced by NicalinΔTMC). 
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vertebrates, with respect to both amino acid identity and protein lengths, (e.g., 71-78 % in the 
zebrafish Danio rerio). In distantly related species such as the fruit fly Drosophila 
melanogaster, the nematode worm Caenorhabditis elegans or the plant Arabidopsis thaliana, 
TMEM147 is even slightly higher conserved than Nicalin and NOMO (~40-50 % conservation 
compared to ~25-35 %).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
In a next step, the question was addressed whether certain areas of TMEM147 and its 
orthologs are particularly conserved. This would be of interest, as it might help to identify 
amino-acid sequences that are essential for TMEM147 function. Therefore, human and 
model organism sequences were aligned using the clustalw2 program and the result was 
visualized using the Jalview software (Fig. 31). In addition, topology prediction data (see 
section 2.3) were integrated. Obviously, the C-terminal ~60 aa are less well conserved than 
the first ~165 aa, suggesting that the C-terminus might be less important for TMEM147 
function. Moreover, a stretch between aa 119 and 140 is highly conserved. Interestingly, a 
larger ER luminal loop has been predicted for this region, namely for aa 121-136. Yet, the 
relevance of this stretch or other conserved regions for Nicalin/NOMO binding or additional 
functions will need further analysis.  
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 Fig. 30: Nicalin, NOMO and TMEM147 sequences and protein sizes are highly conserved in multicellular organisms. Percentage of amino acid (aa) identity and lengths (number of aa) of Nicalin, NOMO and TMEM147 orthologous proteins in 
selected multicellular model organisms are shown. Sequences were retrieved from the Uniprot database and the percentage of 
amino-acid identity compared to the human proteins (‘% identity’) was calculated using the FASTA program. Species specific 
names of the orthologs are not shown; instead ‘Nicalin (Ncl)’, ‘NOMO’ and ‘TMEM147’ (‘T147’) were used for all species. 
Abbreviations: H.: Homo, M.: Mus, X.: Xenopus, D.rerio: Danio rerio, D.melanogaster: Drosophila melanogaster, C.: 
Caenorhabditis, A.: Arabidopsis.  
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Fig. 31: Alignment of TMEM147 orthologs in multicellular organisms. TMEM147 orthologs from Homo sapiens, Mus 
musculus, Xenopus laevis, Danio rerio, Drosophila melanogaster, Caenorhabditis elegans and Arabidopsis thaliana were 
retrieved from the Uniprot database and aligned using the clustalw2 program. The result was visualized using Jalview, and 
topology prediction data (see section 2.3) were integrated. Red bars indicate the position of transmembrane domains, ‘out’ 
marks aa predicted to be ER luminal and ‘in’ marks aa predicted to be exposed to the cytosol. Highlighted in dark blue are aa 
that are identical to human TMEM147 at the respective position, highlighted in light blue are aa that are similar (e.g. 
hydrophobic). In addition, a consensus sequence was generated and brown/yellow bars indicate the degree of conservation at 
the respective position from 0 (0 %) to * = 10 (100 %). In addition, the epitope used to generate the T147.11 antibody is 
indicated. 
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The high degree of Nicalin, NOMO, and TMEM147 conservation indicated that also their 
interaction might be conserved. This was tested by stably expressing a myc-tagged version 
of zebrafish (zf) TMEM147 in human HEK293T cells followed by co-immunoprecipitation and 
immunoblotting studies. Indeed, zfTMEM147 precipitated endogenous human NOMO and 
Nicalin (Fig. 32A). In addition, stable zfNicalin expression resulted in the replacement of 
endogenous human Nicalin and in the stabilization of endogenous human TMEM147 as well 
as NOMO (Fig. 32B; note that zebrafish Nicalin runs at a higher molecular weight than its 
human counterpart and that the amount of overexpressed zfNicalin is underestimated due to 
a lower affinity of the antibody). These results strongly suggested that the interaction of 
TMEM147 with the Nicalin-NOMO complex is evolutionary conserved.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.8  TMEM147, like Nicalin and NOMO, is ubiquitously expressed  
 
Nicalin and NOMO transcripts and proteins have been found in immortalized cell lines 
derived from many different human tissues such as kidney, breast, skin, pancreas, liver, 
uterus or brain (Haffner et al. 2004, Haffner et al., 2007). For TMEM147, expression 
databases such as GeneNote indicated a ubiquitous expression in human tissues. Therefore, 
an immunoblot analysis was performed using several human and non-human cell lines 
originating from a variety of different tissues (Fig. 33; for details see figure legend). Similar to 
the widely expressed ER chaperone Calnexin (bottom panel), TMEM147, Nicalin, and 
NOMO immunoreactivities were found in all cell lines analyzed. Thus, a 
Nicalin/NOMO/TMEM147 complex is presumably present in all tissues. Between cell lines, 
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Fig. 32: Zebrafish TMEM147 (zfT147) interacts with human complex partners. A) Immunoprecipitation of myc-tagged 
zfTMEM147 from overexpressing HEK293T cells resulted in the specific enrichment of endogenous human Nicalin (Ncl) and 
NOMO. B) The stable expression of zfNicalin in HEK293T cells results in the disappearance of endogenous human Nicalin and 
in the elevation of NOMO and TMEM147 expression. Note that the amount of overexpressed zfNicalin is underestimated due to 
a lower affinity of the antibody and that zfNicalin migrates slightly higher than human Ncl (see also Fig. 33).  
 
NOMO
 
Ncl 
 
zfNcl 
wt       zfNcl 
T147 
Calnexin 
36 
kDa 
22 
64 
 
 
 
50 
 
 
 
98 
 
148 
98 
B 
  Results 
 
44 
only minor differences in the expression levels of the complex were observed. The amounts 
of NOMO, Nicalin, and TMEM147 were roughly, but not absolutely, proportional supporting 
the idea of a coordinate expression of the three complex partners (see section 2.4). The 
minor discrepancies (e.g., high Nicalin, but relatively low TMEM147 and NOMO levels in 
MDCK cells) might be explained by cell-type specific differences in transcription and/or 
protein turnover rates. For an unknown reason, human Nicalin migrates faster in an SDS-
PAGE than the dog (MDCK cells) or mouse (P19, 3T3, N2A cells) protein, although protein 
Nicalin (precursor) size is 563 aa and two predicted glycosylation sites are present in all 
three species. Possible explanations would be differences in the extent of glycosylation or 
precursor protein processing between the species. Also splice variants may occur, although 
this is not supported by database entries. Alternatively, a partial folding despite the 
denaturing conditions of the SDS-PAGE may alter the running behavior of either human or 
non-human Nicalin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
During zebrafish development nicalin and nomo mRNAs are expressed maternally and 
throughout early embryonic stages, in agreement with their proposed role in Nodal signaling 
(Haffner et al., 2004). A continuous expression of Nicalin and NOMO proteins from the 
fertilized egg until 5 day old larvae could be confirmed by an immunoblot analysis using 
zebrafish total protein lysates (Fig. 34A). Unfortunately, TMEM147 levels were under the 
detection limit of the T147.11 antibody in these lysates. To analyze the expression pattern of 
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Fig. 33: TMEM147, like Nicalin and NOMO, is widely expressed in human and non-human cell lines. Membrane protein 
lysates were analyzed by immunoblotting using specific NOMO, Nicalin, and TMEM147 antibodies. As a control, expression 
levels of the ER chaperon Calnexin are shown. HEK293T, human embryonic kidney cells; HeLa, human epithelial cervical 
cancer cells; HepG2, human hepatocellular liver carcinoma cells; SHSY5Y, human neuroblastoma cells; A431, human 
epidermoid carcinoma cells; MCF7, human breast adenocarcinoma cells; Panc-1, human pancreatic carcinoma cells; C8161, 
human melanoma cells; MDCK, Madin-Darby canine kidney epithelial cells; P19, mouse embryonic carcinoma cells; 3T3 
mouse fibroblast cells; N2A, mouse neuroblastoma cells. 
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tmem147 mRNA, in situ hybridization was performed in fixed embryos at different stages. As 
representative results, the stainings for 4-cell, 64-cell, 12 hours and day 2 (48 hours) 
embryos are shown. The lack of a labeling with the sense probe demonstrates the specificity 
of the antisense probe (Fig. 34B). A maternal and zygotic expression of tmem147 mRNA 
was detected. At 12 hours and 2 days post fertilization no tissue- or organ-specific but rather 
ubiquitous expression was observed. Similar spatiotemporal expression patterns have been 
shown for zfNicalin and zfNOMO (Haffner et al., 2004) further suggesting that the interaction 
between TMEM147 and Nicalin/NOMO is functionally relevant.  
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Fig. 34: Nicalin, NOMO and TMEM147 are widely expressed in zebrafish development. A) Time-course of Nicalin, NOMO and 
TMEM147 protein expression during zebrafish embryonic development until day 5 post fertilization, analyzed by immuboblotting. 
Total zebrafish protein lysates were used (see section 4.8.3). A continuous expression of Nicalin and NOMO was observed. ß-
actin was used as a loading control. B) In situ hybridization of tmem147 mRNA in fixed zebrafish embryos was performed at 
different stages, represented here by the stainings for 4-cell, 64-cell, 12 hours, and day 2 embryos. A maternal expression (4-cell 
stage) and ubiquitous zygotic expression of tmem147 mRNA was revealed. The lack of a labeling with the sense probe 
demonstrated the specificity of the antisense probe. (hpf, hours post fertilization) 
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2.9 Towards the Nicalin interactome using SILAC 
 
In the experiments described so far, TMEM147 could be identified as a novel core 
component of the Nicalin-NOMO complex. Although the combined molecular weight of the 
three proteins is in agreement with the native size of the complex (Haffner et al., 2007), the 
existence of additional components cannot be ruled out. Moreover, the identification of 
TMEM147 did not lead to a better understanding of the cellular function of the complex, 
which still remains elusive. Therefore, it is of high importance to identify additional binding 
partners, which might represent either further complex components or functionally important 
transient interactors. Such proteins are difficult to find because they might be very small or 
bind too transiently to be detected by conventional purification and staining methods. To 
overcome this problem, the possibility was explored to analyze the complete Nicalin 
interactome by a mass spectrometry approach. Due to its high sensitivity, it is the method of 
choice to identify even minute amounts of a protein in a sample. However, it also carries the 
risk of detecting a high percentage of false positives, mainly because a quantitative 
comparison between different measurements, e.g. sample and control, is very difficult. To 
avoid this problem, a technology was used which allows the analysis of two samples in a 
single measurement. SILAC (stable isotope labeling using amino acids in cell culture) is a 
technique based on the metabolic labeling of cellular proteins in cultured cells with ‘heavy’ 
stable isotopes which can be distinguished from their natural counterparts by their higher 
masses (Ong et al., 2002). This allows a quantitative comparison of the proteome from cells 
grown in the presence of heavy isotope-labeled amino acids with the proteome from control 
cells grown in the absence of heavy isotopes. Thus, the distinction between true and artificial 
hits becomes much more precise (Ong et al., 2002). To identify additional interactors of the 
Nicalin-NOMO complex, HEK293T/Ncl-myc cells were isotope-labeled for two weeks by 
cultivation in lysine/arginine-free medium supplemented with 5,5,6,6-D4-lysine and 13C6-
arginine (see section 4.4.3). Control HEK293T cells were cultured in medium supplemented 
with unlabeled lysine and arginine. Anti-myc-immunoprecipitations from large-scale 
membrane protein preparations from wild-type and Nicalin-myc expressing cells were 
performed separately. After the binding step both samples were combined, the precipitated 
material eluted, separated on an SDS-gel in a single lane, and stained by Coomassie Blue. 
The gel lane comprising the complete molecular weight range was cut into 11 pieces, 
proteins digested by trypsin, extracted, and subjected to LC-MS/MS analysis (Fig. 35). 
As trypsin cleaves peptide bonds after arginine or lysine, all peptides originating from Ncl-
myc cells were theoretically labeled with 5,5,6,6-D4-lysine or 13C6-arginine. As a 
consequence, identified peptides with a heavy/light (H/L) ratio above a certain threshold, in 
this case 1.8, were considered as true hits (Tab. 2). However, one prerequisite for this 
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approach is a more or less complete labeling of all cellular proteins and it turned out that 
even after two weeks of cultivation more than one third of precipitated Nicalin was still 
unlabeled (~30 % of Nicalin peptides were not labeled ‘heavy’). This could be explained by 
the stability of the Nicalin-NOMO complex, but also by a slowed metabolism of the cells in 
the medium which contained filtered serum. Therefore, for generating a list of the most 
significant hits not only the heavy/light (H/L) ratio was taken into consideration, but also by 
the overall intensity of the MS signals and the overall peptide coverage of the proteins 
detected, and weighted 1:1:1 (Table 2). As a validation of the approach, NOMO and Nicalin 
are found at the positions one and two and TMEM147 at position five. About 60 % of the 
potential interactors in the list and nine of the ten top hits are ER-associated proteins, an 
indication for the specificity of the approach. According to their known (or putative) function, 
the majority of the identified proteins can be arranged in functional groups (Tab. 2; discussed 
in section 3.4). Only few proteins with a destination further downstream of the early secretory 
pathway were found, and no factors could be specifically linked to Nodal/TGFβ signaling. 
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Fig. 35: Work-flow of the SILAC/Nicalin-IP/MS experiment. HEK293T/Ncl-myc and wild-type cells were grown for two weeks 
in 5,5,6,6-D4-lysine/13C6 arginine medium and normal medium, respectively. Membrane protein lysates were subjected to an 
anti-myc IP. After washing, beads with precipitated material from wt and Ncl-myc cells were united and boiled. The sample was 
run on a NuPAGE 4%-12% Bis-Tris gel (Invitrogen) and stained with Coomassie Blue. The whole protein lane was cut into 11 
pieces. Proteins within gel pieces were subjected to trypsin cleavage, extracted, and LC-MS/MS was performed. Peptides 
originating from Ncl-myc cells were either 5,5,6,6-D4-lysine (Lys4) or 13C6 arginine (Arg6) labeled. (PGS, protein G sepharose) 
PGS 
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# 
Ø Protein Name 
MW 
[kDa] 
Ratio 
H/L 
Cover. 
[%] Intensity 
# 
Rat. 
# 
Cov. 
# 
Int. Protein context 
1 NOMO1/2/3 139.4 3.64 60.3 1843000000 16 2 2 ER NicNO complex 
2 Nicalin 63.0 2.88 66.1 2982000000 24 1 1 ER NicNO complex 
3 BNIP1 26.1 4.05 36.4 55750000 12 8 8 ER SNARE 
4 Erlin1/2* 37.8 5.38 31.0 25031000 6 14 14 ER lipid raft 
5 TMEM147 25.3 4.38 30.4 41647000 10 15 10 ER NicNO complex 
6 p31 29.3 3.71 44.0 10610000 15 3 23 ER SNARE 
7 SERCA2B*  114.8 4.42 22.0 30676000 9 24 13 ER Ca2+ ATPase 
8 VDAC2* 36.3 2.60 31.6 71940000 32 12 5 Mitochondrium 
9 Sec22b* 24.6 3.38 22.9 44307000 18 23 9 ER SNARE 
10 Grp78/BiP 72.4 2.22 41.8 116560000 49 4 4 ER chaperone 
11 Rap2b 20.5 3.05 31.7 9676800 20 11 27 PM (lipid raft) 
12 Flotillin 1 47.4 2.69 19.7 117230000 29 28 3 PM lipid raft 
13 AAA domain prot. 1 40.7 2.88 24.7 10147000 25 21 26 ATPase hexamer 
14 Flotillin 2 41.7 2.11 32.7 58639000 56 10 7 PM lipid raft 
15 Ddost subunit 48 kDa* 50.8 2.52 20.2 35475000 35 27 12 ER translocation 
16 SRPR subunit β 29.7 2.37 39.5 9540300 42 5 28 ER translocation 
17 VCP/P97* 89.2 2.70 19.1 19637000 28 30 18 ER ATPase 
18 Syntaxin 18 38.7 22.56 11.6 10533000 2 54 24 ER SNARE 
19 Emerin 29.0 2.91 27.6 3279300 23 17 44 Nuclear membrane 
20 Rab1B 22.2 2.21 24.4 24879000 50 22 15 ER/Golgi vesicles 
21 VDAC1* 30.6 2.03 27.0 70780000 64 18 6 Mitochondrium 
22 60S P0 34.3 1.90 38.5 41571000 73 6 11 Ribosome 
23 SPC subunit 22 kDa 20.8 3.83 21.3 2163200 14 25 52 ER translocation 
24 NRas 21.2 2.96 24.9 2187000 21 20 51 Golgi/PM GTPase 
25 Reticulocalbin 2 36.9 5.15 19.2 1667700 8 29 59 ER Ca2+ binding 
26 SPC subunit 18 kDa 20.6 3.27 15.1 4438000 19 44 33 ER translocation 
27 RhoA 21.8 2.10 36.3 6967500 57 9 31 GTPase cytoskelet. 
28 40S S12 14.4 2.18 29.0 8617400 52 16 30 Ribosome 
29 HLA I. A-3 α chain 36.9 2.38 16.9 11618000 41 37 22 HLA complex 
30 NSF 82.7 2.64 15.6 9239900 31 42 29 ATPase (SNAREs) 
31 Rab35 23.0 2.56 12.9 19236000 33 50 19 GTPase PM 
32 Sec61 subunit β  9.8 2.50 37.9 1226900 36 7 63 ER translocation 
33 Rab9A 22.8 1.97 25.4 18397000 68 19 20 GTPase ubiquitous 
34 Peroxisom. Prot. 11A 28.4 22.61 8.1 2693200 1 64 47 Peroxisome 
35 TM protein 70 29.0 2.40 15.8 4370000 40 40 34 Mitochondrium 
36 Sec61 subunit α1  52.3 2.34 12.6 12884000 44 51 21 ER translocation 
 
Tab. 2: Potential interactors identified by the SILAC experiment. Hits were listed according to their heavy/light (H/L) peptide 
ratio, the degree of protein sequence coverage by the detected peptides (Cover. [%]), and the overall intensity of the signals 
obtained from the particular protein (Intensity), weighted 1:1:1. In addition, a ratio of 1.8 was used as a cut-off to exclude 
unspecific interactions. For each criterium, a ranking (#) was obtained, eventually the overall position of the hits was calculated 
as an average (# Ø). Abbreviations: MW, molecular weight; BNIP1, BCL2/adenovirus E1B 19kDa interacting protein 1; Erlin1/2, 
ER-lipid enriched protein 1/2; SERCA2B, sarcoplasmic/endoplasmic reticulum calcium channel 2B; VDAC1/2, voltage-
dependent ion channel 1/2; Grp78, glucose-related protein; BiP, binding protein; Rap2b, Ras-associated protein 2b; AAA 
domain prot. 1, AAA domain containing protein 1; Ddost, dolichyl-diphosphooligosaccharide-protein-glycosyltransferase; SRPR, 
signal recognition particle receptor; VCP, valosine-containing protein; Rab1B, Ras associated binding protein; 60S P0, 60S 
ribosomal protein 0; SPC, signal peptidase complex; NRas, neuroblastoma RAS viral oncogene homolog; RhoA, Ras homolog 
A; HLA I, human leukocyte antigen I; NSF, N-ethylmaleimide-sensitive fusion protein; Rab 35/9A, Ras associated binding 
protein 35/9A; Peroxisom. Prot. 11A, peroxisomal protein 11A, TM protein 70, transmembrane protein 70s; NicNO, Nicalin-
NOMO; SNARE, soluble NSF attachment receptor; PM, plasma membrane. Proteins denoted with * were also identified by a 
recent analysis of the γ-secretase interactome (Wakabayashi et al., 2009), indicating that they might be common 
contaminations and/or general interactors of ER membrane protein complexes. 
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Fig. 36: Co-IP/immunoblotting indicates an interaction between the Nicalin-NOMO complex and ER SNAREs. Anti-myc IPs 
were performed from membrane protein lysates of wild-type (wt) and stably transfected HEK293T cells. Co-isolation of the ER-
SNAREs is proportional to the amount of Nicalin-NOMO complex precipitated. While complex levels are elevated by Nicalin (Ncl) 
overexpression, NOMO-overexpressing cells only contain wild-type complex levels. C-terminally truncated Ncl-ΔC apparently is 
partially deficient in NOMO and ER-SNARE binding. Calnexin, Grp78/BiP and VCP/p97 specific antibodies were used as controls. 
Four members of the SNARE (soluble NSF attachment receptor) family of vesicle fusion 
factors (Syntaxin 18, BNIP1, Sec22b and p31) were identified as potential Nicalin interactors 
with a high ratio, coverage and intensity. They have been shown to localize to the ER and to 
form a complete SNARE complex (Aoki et al., 2008). This Syntaxin 18 complex has been 
proposed to be involved in homotypic and heterotypic membrane fusion events regulating ER 
homeostasis as well as vesicle trafficking between the ER and downstream compartments of 
the secretory pathway (Okumura et al., 2006; Hatsuzawa et al., 2009; Iinuma et al., 2009). It 
is regulated by the vesicle-fusing ATPase NSF (N-ethylmaleimide-sensitive factor), which is 
also present in the hit list. The interaction was confirmed by immunoprecipitation of Nicalin, 
NicalinΔC, NOMO and subsequent immunoblotting (Fig. 36). Syntaxin 18, BNIP1, Sec22b 
and p31 were all detected in the precipitated material, but the amount was considerably less 
when compared to NOMO indicating a substoichiometric ratio. In addition, the expression of 
none of these proteins was elevated in Nicalin-myc cells (Fig. 36, input lanes) further 
suggesting a transient interaction. 
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Two observations strongly support the idea that this interaction is specific and occurs 
between the entire complexes: (1) in NOMO-myc cells, which contain only wild-type levels of 
the Nicalin-NOMO complex, the amount of SNARE proteins detected in the 
immunoprecipitate was strongly reduced, (2) in Nicalin-ΔC cells no specific interaction could 
be detected, in agreement with our finding that this truncated protein is at least partially 
defective in complex formation (reduced NOMO binding, see Fig. 36; reduced NOMO and 
TMEM147 stabilization, see Fig. 27 and 28). 
To corroborate the binding results, the subcellular localization of Nicalin, Syntaxin 18 and 
BNIP1 was compared to that of Nicalin in HeLa cells by immunofluorescence microscopy. 
Syntaxin 18 with an N-terminal FLAG-epitope tag and BNIP1 with a C-terminal V5-epitope 
tag were expressed and co-staining was performed with endogenous Nicalin (Fig. 37). 
Overexpression of Syntaxin 18 and BNIP1 leads to large aggregates at the endoplasmic 
reticulum, likely as a result of an increased fusion activity of ER membranes (Hatsuzawa et 
al., 2000; Nakajima et al., 2004). This observation was confirmed in the HeLa cells Fig. 37, 
indicated by arrows) and endogenous Nicalin almost perfectly co-localized with Syntaxin 18 
and BNIP1 within the aggregates as well as in other regions of the cell. A potential 
physiological role of the interaction is discussed in section 3.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 37: Nicalin and ER SNAREs co-localize. Immunofluorescence microscopy of transfected HeLa cells stained with anti-tag 
antibodies recognizing the transfected SNARE proteins and with a monoclonal anti-Nicalin antibody. Overexpression of 
Syntaxin18 and BNIP1 leads to aggregation of ER membranes (indicated by arrows), as reported by Hatsuzawa et al. (2000) and 
Nakajima et al. (2004). Endogenous Nicalin co-localizes with both proteins in these structures as well as in normal ER. 
Costaining was also observed between Nicalin and Sec22b or p31 (not shown). 
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10 µm 
3.  Discussion 
 
3.1 A novel core component of the Nicalin-NOMO complex 
 
In the present work the possibility was explored that the Nicalin-NOMO membrane protein 
complex, whose composition and molecular function is only poorly understood, may contain 
additional protein components, preferably in the low-molecular-weight range. Previously, a 
Nicalin affinity purification approach had led to the identification of NOMO and the use of a 
modified procedure now allowed the isolation of a ~22-kDa protein from human HEK293T 
cells, which could be identified as TMEM147 by mass spectrometry analysis. TMEM147 is a 
novel and uncharacterized polytopic membrane protein predicted to be largely embedded 
within the membrane. A variety of data are presented which leave little doubt about the 
hypothesis that TMEM147 is a genuine component of the Nicalin-NOMO complex: 
  
1. The co-immunoprecipitation analysis revealed a roughly stoichiometric interaction 
between Nicalin, NOMO, and TMEM147. 
2. All three proteins are conserved in multi-cellular organisms to a similar extent and 
zebrafish and human proteins interact in cell culture.  
3. Similar to Nicalin and NOMO, TMEM147 appears to be ubiquitously expressed as 
indicated by immunoblot analysis of different cell lines and mRNA in situ hybridization 
in zebrafish embryos. 
4. No transport of TMEM147 beyond the early secretory pathway was observed by 
immunofluorescence microscopy or density gradient centrifugation, in agreement with 
the intracellular localization of Nicalin and NOMO.  
5. Similar to Nicalin, the overexpression of TMEM147 leads to the replacement of the 
endogenous protein demonstrating that the TMEM147 steady-state levels are tightly 
regulated. 
6. The RNAi-mediated downregulation of TMEM147 results in the reduction of Nicalin 
and NOMO expression and vice versa strongly suggesting that all three factors 
stabilize each other within the complex (see also section 3.3).  
7. Nicalin controls the expression levels of both TMEM147 and NOMO by a post-
transcriptional mechanism (see also section 3.3). 
 
Although no other major Nicalin interactor was found and the combined molecular weights of 
Nicalin (~60 kDa), NOMO (~130 kDa), and TMEM147 (~22 kDa) are in good agreement with 
the native size of the complex (200-220 kDa), the existence of additional complex 
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components, which might be of low molecular weight or not elevated in Nicalin-
overexpressing cells, cannot completely be ruled out.  
TMEM147 shows no significant homology to any other known protein nor were functional 
domains detected. Thus, a possible function could not be inferred from its amino-acid 
sequence. According to topology prediction programs, TMEM147 contains seven 
transmembrane domains and is largely embedded within the hydrophobic environment of the 
membrane. Its N-terminus is predicted to reside within the ER lumen and its C-terminus to 
face the cytosolic side of the membrane. Thus, size and topology are highly reminiscent of 
the γ-secretase component APH-1 and a variety of data presented in this thesis suggest that 
TMEM147 and APH-1 might play at least partially similar roles in the assembly of their 
respective complexes. In any case, one consequence of the identification of TMEM147 as a 
third component of the complex is that the Nicalin-NOMO complex does not, as previously 
thought, comprise only two transmembrane domains, but a total of nine (Fig. 38). Thus, a 
contribution of the transmembrane regions of the complex in addition to the prominent Nicalin 
and NOMO luminal domains to the function of the complex now appears more likely. 
 
 
 
 
 
 
 
 
 
  
    
NOMO TMEM147 Nicalin 
 
 
 
       
    
cytosol 
ER 
lumen 
Fig. 38: Schematic illustration of the components of the Nicalin-NOMO complex. Nicalin and NOMO are type-I 
transmembrane proteins. The 7 transmembrane topology of TMEM147 was predicted by the PRODIV-TMHMM algorithm as a part 
of the TOPCONS server and is reminiscent of the γ-secretase component APH-1. 
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3.2  Nicalin-NOMO complex and γ-secretase assembly occur stepwise  
 
For γ-secretase, a stepwise mode of complex assembly and subsequent transport has been 
proposed (reviewed by Kaether et al., 2006; Spasic and Annaert, 2008). Different studies 
agree on the initial formation of a Nicastrin (NCT)/APH-1 subcomplex (Hu and Fortini, 2003; 
LaVoie et al., 2003), which is stable even in the absence of Presenilin (PS) and PEN-2 
(Shirotani et al., 2004) and more resistant to detergent dissociation than other subcomplexes 
(Fraering et al., 2004). In the prevailing scenario for the following steps, the nascent PS 
holoprotein is stabilized in a high-molecular-weight inactive PS/NCT/APH-1 complex, until 
PEN-2 triggers endoproteolysis of PS and ER export of the complex (Kim et al., 2004; Capell 
et al., 2005). The assembled γ-secretase continues its way through the secretory pathway 
and reaches its final destinations, the plasma membrane and the late secretory pathway 
compartments (Kaether et al., 2002; Capell et al., 2005; Chyung et al., 2005).  
In contrast to γ-secretase, no transport of the Nicalin-NOMO complex beyond the early 
secretory pathway could be observed. Therefore, the assembly mode of the Nicalin-NOMO 
complex does not reflect the need to regulate the ER export of the complex, as it may be the 
case for γ-secretase. Nevertheless, a hierarchical assembly of the complex is indicated by 
the following observations:  
 
1. Upon induced expression of Nicalin the stabilization of NOMO appears to precede that of 
TMEM147. 
2. A subcomplex consisting only of Nicalin and NOMO can be immunoisolated from cell 
lysates when Nonidet P-40 is used as a detergent.  
3. Whereas the interaction between Nicalin and NOMO is most likely mediated by their 
ectodomains, TMEM147 appears to bind to Nicalin’s transmembrane domain.  
 
These findings fit into a model where the formation of a Nicalin-NOMO subcomplex, 
mediated by their luminal domains, initiates complex assembly, followed by the addition of 
TMEM147 (Fig. 39). Apparently, the Nicalin transmembrane domain is essential for 
TMEM147 binding, but further analysis is needed to test if it is also sufficient. In any case, 
this mode of TMEM147 binding is analogous to APH-1 in γ-secretase, where the NCT 
transmembrane domain has been demonstrated to be absolutely required for the NCT/APH-
1 interaction (Capell et al., 2003). However, TMEM147 differs from APH-1 in being 
dispensable for the formation of the Nicalin-NOMO subcomplex, whereas APH-1 is 
considered a scaffold protein for the assembly of γ-secretase. Another difference is the 
stability of the Nicalin-NOMO subcomplex in the presence of the detergent NP-40. NP-40 is 
known to completely disrupt γ-secretase, which is believed to be held together mainly by 
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interactions between transmembrane domains (LaVoie et al., 2003). This difference can be 
explained by the two large ER luminal ectodomains mediating the interaction between Nicalin 
and NOMO. In contrast, NCT is the only component with a prominent luminal domain in γ-
secretase. 
Because of the different subcellular localizations of mature γ-secretase and the Nicalin-
NOMO complex, they use different targeting mechanisms. During complex assembly, 
immature γ-secretase is kept in the ER by retention signals which might be located in the 
transmembrane domain 1 of PEN-2 (Fassler et al., 2010), in the ER-luminal Presenilin C-
terminus close to or even embedded within the membrane (Kaether et al., 2004) and in the 
Presenilin transmembrane domain 4 (Fassler et al., 2010). After completion of the assembly, 
these signals are believed to be masked allowing the transport of fully assembled γ-
secretase to the plasma membrane (Kaether et al., 2004; Kaether et al., 2006; Fassler et al., 
2010). In contrast, the Nicalin-NOMO complex is kept within the ER even in its fully 
assembled form. The Nicalin C-terminus, which contains a motif resembling a classical ER 
retention signal, was shown to be sufficient to mediate the ER retention/retrieval of a plasma 
membrane protein. However, NicalinΔC lacking this motif still localizes to the ER 
demonstrating that the in vivo situation might be more complex. 
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Fig. 39: Stepwise assembly of Nicalin-NOMO complex and γ-secretase. A simplified model. The assembly of the Nicalin-NOMO 
complex (top) appears to be triggered by the binding of NOMO to Nicalin, likely mediated by their luminal domains, followed by the 
addition of TMEM147 in the transmembrane region. The heterotrimeric complex is retained in the ER by an unknown mechanism 
(the illustrated interactions between TMEM147 transmembrane domains and Nicalin/NOMO are just an example for a possible 
interaction). γ-secretase assembly (bottom) is initiated by the formation of a Nicastrin/APH-1 intermediate, which incorporates the 
Presenilin holoprotein. Finally, the binding of PEN-2 triggers the ER exit of the whole complex. On its way through the secretory 
pathway, γ-secretase undergoes maturation, e.g. Presenilin autoproteolysis and complex glycosylation of Nicastrin. The γ-secretase 
illustration integrated knowledge about the exact molecular interactions within the complex (adapted from Kaether et al. 2006). In 
this simplified model neither all interactions in the complex nor details about the three dimensional structure of γ-secretase are 
reflected. 
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3.3  Nicalin is the master regulator of the Nicalin-NOMO complex  
 
For the assembly of γ-secretase, a concept was proposed in which individual components 
are stabilized by complex formation and excess molecules are rapidly degraded (Thinakaran 
et al., 1997). This hypothesis was confirmed by a variety of studies which demonstrated that 
downregulation of one complex component results in the destabilization of other components 
(see section 1.1.2). However, only the co-expression of all four components leads to an 
increase in catalytic activity (Edbauer et al., 2003; Hu and Fortini, 2003; Kimberly et al., 
2003) indicating that under wild-type conditions they are not produced in significant excess. 
Thus, there appears to be no general rate-limiting factor of the γ-secretase complex and it 
has been proposed that the least abundant complex member may vary by cell type (Kimberly 
et al., 2002).  
A mutual stabilization mechanism has also been demonstrated for Nicalin and NOMO 
(Haffner et al., 2007) and now been extended to TMEM147 (this thesis). TMEM147 is 
unstable in the absence of one of its complex partners and its own downregulation results in 
the reduction of Nicalin and NOMO protein levels. In contrast to γ-secretase, this mutual 
stabilization has been suggested to function as specific regulatory mechanism in the case of 
the Nicalin-NOMO complex (Haffner et al., 2007). The synthesis of Nicalin, like that of all γ-
secretase components, appears to be strictly regulated, whereas NOMO is produced in 
excess. The data presented in this thesis show that this is also the case for TMEM147. The 
enhanced expression of Nicalin is sufficient to increase the cellular levels of both NOMO and 
TMEM147 by a post-transcriptional mechanism. In contrast, overexpression of TMEM147 
and NOMO, either alone or in combination, does not elevate endogenous Nicalin levels nor 
the levels of the respective other complex partner. The existence of a pool of excess NOMO 
and TMEM147 molecules under exogenous conditions is directly shown by proteasome 
inhibition in wild-type cells leading to an increase in NOMO and TMEM147, but not Nicalin 
expression. This result in addition indicates that excess complex components are degraded 
by the proteasome. 
Thus, a special role can be assigned to Nicalin, which has never been observed for Nicastrin 
or any other γ-secretase component: No matter how high Nicalin was overexpressed, the 
other complex components were always found to adapt via stabilization of excess 
monomers. Nicalin can be considered the rate-limiting factor which binds other complex 
components and thus triggers complex assembly (Fig. 40).  
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This situation offers the cell a potent mode to regulate complex levels solely via Nicalin, 
which in turn raises the question if there is a transcriptional and/or translational control of 
Nicalin expression. The possibility that Nicalin and the complex might fulfill a chaperone 
function in the ER, gave rise to the idea that Nicalin levels may be elevated after ER stress 
Fig. 40: Nicalin regulates NOMO and TMEM147 expression. A) Under steady-state conditions in wild-type cells, TMEM147 
and NOMO excess molecules which do not ‘encounter’ a Nicalin molecule are rapidly degraded involving retrotranslocation and 
cytosolic proteasomes (ER associated degradation). B) Upon proteasome inhibition, excess TMEM147 and NOMO monomers 
are stabilized. C) Nicalin overexpression stabilizes TMEM147 and NOMO by complex formation, thereby preventing their 
degradation. 
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like the ER ‘heat shock’ chaperones Grp78/BiP and Grp94 (reviewed by Wegele et al., 
2004). However, in this work different forms of ER stress conditions failed to induce Nicalin 
expression. This was in agreement with the inability to identify binding sites for transcription 
factors that regulate the induction of certain proteins upon ER stress, such as the activating 
transcription factors 4 or 6 (reviewed by Ye and Koumenis, 2009), in association with the 
nicalin gene (using the PROMO 8.3 program). Instead, a recent study (Myslinski et al., 2006) 
reported the presence of six binding sites of the transcription factor STAF/ZNF143 in the 
Nicalin promoter (Fig. 41A), but STAF/ZNF143 binding sites are associated with a variety of 
human genes without overlapping function (Fig. 41B) and no context for Nicalin-NOMO 
function could be deduced from this observation. Nevertheless, the finding may be worth 
further analysis, as the sites are evolutionary conserved (Fig. 41A) and no other human gene 
possesses such a high number of STAF/ZNF143 binding sites in its promoter region.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 41: Cross-species conservation of six STAF/ZNF143 binding sites in Nicalin. A) Multiple sequence alignment of human 
(h), dog (d), mouse (m), and rat (r) Nicalin promoter regions performed with ClustalW. Identical nucleotides are denoted with *. 
The putative STAF/ZNF143 binding sites 1-6 have been highlighted in gray. In addition, an ACTACAN (nucleotide code; N, any 
nucleotide) submotif, associated with STAF/ZNF143 binding sites 1-4, is in boldface. The transcriptional start site is indicated by 
an arrow. A gap was introduced, so that ~ 200 bp characterized by low homology are not shown. B) Categorization of the 
hStaf/ZNF143 target genes. Genes targeted by hStaf/ZNF143, whose function was known or could be inferred, were classified 
according to the function of the encoded protein. Adapted from Myslinski et al., 2006. 
 
[...~ 200 bp...] 
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3.4  Analysis of the Nicalin interactome 
 
The Nicalin-NOMO complex has been shown to be involved in the Nodal signaling pathway 
in zebrafish embryos (Haffner et al., 2004), but the molecular mechanism mediating this 
effect is unknown. Based on the ER-localization of the complex, two modes of action were 
conceivable: an influence on the secretion of the ligand Nodal or a regulation of the 
trafficking of Nodal receptors or co-receptors. However, co-isolation and co-regulation 
studies using these molecules did not lead to clear results and made an unbiased approach 
necessary to identify possible interactors which could provide a link between the complex 
and the Nodal pathway. The approach used to identify NOMO and TMEM147 - Nicalin 
affinity purification with subsequent protein staining - proved not sensitive enough for the 
detection of transient interactors. Therefore, the purification was combined with mass 
spectrometry analysis to identify co-purified proteins. To minimize the detection of false 
positives, a common problem in mass spectrometry approaches, stable isotope labeling 
using amino acids in cell culture (SILAC) was used and only hits with a heavy/light ratio 
above 1.8 were considered true interactors resulting in a list of 36 proteins. To identify the 
most promising interactors, signal intensity and protein coverage data were included in the 
analysis in addition to the heavy/light ratio (see Tab. 2). NOMO as well as TMEM147 were 
among the top hits confirming the suitability of this approach. Its specificity was 
demonstrated by the fact that nine of the ten top hits were ER-associated proteins. However, 
none of the potential interactors represented an obvious link to the observed phenotypes 
from animal studies, i.e. Nodal signaling or nAChR assembly (see sections 1.2 and 3.5).  
The most interesting group of proteins on the hit list were four SNARE proteins - Syntaxin 18, 
BNIP1, Sec22b and p31 - previously shown to form the Syntaxin 18 complex involved in the 
retrieval of proteins from the Golgi apparatus back to the ER (Hatsuzawa et al., 2000). The 
interaction between Nicalin and all four members of the SNARE complex was confirmed by 
co-isolation/immunoblotting and co-localization was demonstrated by immunofluorescence 
microscopy. An effect on the function of this complex by the Nicalin-NOMO complex could 
result in alterations in the trafficking of molecules involved in Nodal signaling. Alternatively, 
the Syntaxin 18 complex might also be responsible for the ER retrieval of the Nicalin-NOMO 
complex. However, SNARE proteins mediate the fusion of vesicles to target membranes, but 
are usually not involved in the recruitment and binding of cargo proteins in the respective 
vesicles (reviewed by Wickner and Schekman, 2008). Adapter proteins, on the other hand, 
that mediate this recruitment, were not among the hits. In addition, the Syntaxin 18 complex 
has been attributed other important functions such as ER subdomain organization (Iinuma et 
al., 2009). Thus, the relevance of this interaction will need further investigation. 
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Another interesting group among the potential Nicalin interactors were ER-residual proteins 
implicated in protein translocation through the ER membrane, such as Grp78/Bip, Ddost 
(dolichyl-diphosphooligosaccharide-protein glycosyltransferase) 48 kDa subunit, SRPR 
(signal-recognition particle receptor) subunit β, SPC (signal-peptidase complex) 22 kDa 
subunit, SPC (signal-peptidase complex) 18 kDa subunit, the translocon subunits Sec61 α 
and Sec61 β and ribosomal proteins. These interactions could not be explained by the 
precipitation of nascent Nicalin interacting with translocation factors, as the precipitated 
Nicalin was tagged C-terminally. Interestingly, a recent proteomics study (Gilchrist et al., 
2006), which analyzed the secretory pathway by the isolation of its compartments and 
subsequent mass spectrometry, indicated an enrichment of Nicalin and NOMO in the rough 
ER, where translocation occurs. Moreover, the distribution of Nicalin and NOMO between 
rough ER, smooth ER and Golgi apparatus observed in that study was very similar to that of 
the translocon component Sec61 α (Fig. 42).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Following the rationale of the study (Gilchrist et al., 2006), this ‘co-clustering’ is an indication 
for a function of the Nicalin-NOMO complex in the context of protein translocation into the 
ER. Indeed, the proteins enriched in the ‘Sec61 α cluster’ comprised translocation factors 
such as Ddost subunits, translocon subunits and ribosomal proteins. On the other hand, it 
also contained proteins unrelated to translocation such as enzymes involved in ER lipid 
metabolism, while proteins involved in translocation such as signal peptidase were found in 
different clusters. Thus, further (biochemical) data are needed to proof or disproof a 
functional relationship between Nicalin and the translocation machinery. Yet, further support 
for an involvement of the Nicalin-NOMO complex in translation/ER quality control came from 
Fig. 42: ‘Co-clustering’ of proteins of the early secretory pathway. A) Rough ER membrane (RM), smooth ER membrane 
(SM), and Golgi (G) data (n = 3) were averaged and a heat map was generated. Clusters containing Sec61, p97 and Calnexin as 
markers were selected (Pearson correlation coefficient > 0.90). B) Mean values for proteins in each of these three clusters were 
plotted individually (normalized % total peptides). Both Nicalin and NOMO showed a similar RM/SM/G distribution as the 
translocon subunit Sec61 α, indicating a functional relationship. Adapted from Gilchrist et al., 2006. 
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a study that analyzed the interactions of the secreted human hepatic lipase (HL) during its 
maturation in chinese hamster ovary (CHO) cells by tandem-affinity purification (TAP) and 
mass spectrometry (Doolittle et al., 2009; Fig. 43). 16 interacting ER proteins were identified, 
including NOMO (but not Nicalin) and components of the two major ER chaperone systems, 
the BiP/Grp94 and the Calnexin/Calreticulin system. However, NOMO was only found to 
interact when cells were stressed using dithiothreitol, a reducing agent that causes protein 
unfolding, indicating that the interaction is only triggered under enhanced stress conditions, 
which might lead to artificial interactions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some of the potential Nicalin interactors were identical to γ-secretase interactors identified 
recently by a study based on a tandem-affinity purification (TAP)/mass spectrometry 
approach (Wakabayashi et al., 2009). Among these proteins were voltage dependent ion 
channel (VDAC), ER lipid raft enriched (Erlin) proteins, sarcoplasmic/endoplasmic reticulum 
calcium ATPase (SERCA), dolichyl-diphosphooligosaccharide-protein-glycosyltransferase 
(Ddost) subunits and Sec22b, indicating that these factors may be common contaminations 
of (ER) membrane affinity purifications and/or (maybe less likely) they generally interact with 
(ER) membrane protein complexes. 
In summary, the combination of SILAC, co-isolation and mass spectrometry presented in this 
work is a promising approach for the identification of novel Nicalin interactors. However, 
subsequent studies will have to analyze the identified interactions in more detail. The 
described analysis needs to be repeated in wild-type cells with endogenous Nicalin to avoid 
overexpression artifacts. To that end, an anti-Nicalin antibody has to be generated which 
allows the precipitation of the intact complex. Alternatively, another purification approach 
could be developed to purify the endogenous complex, as has been achieved for the γ-
secretase complex (Winkler et al., 2009).  
Fig. 43: Hepatic lipase may interact with NOMO during maturation. Diagram comparing ER proteins co-purifying with TAP-
tagged hepatic lipase (HL-TAP) in untreated CHO cells or cells treated with dithiotreitole (DTT), a reducing agent that causes 
protein unfolding. The shaded areas represent proteins that are the strongest candidates for roles in HL maturation and/or 
degradation. (Nodal modulator 1, NOMO1). Adapted from Doolittle et al., 2009 
BiP 
Reticulocalbin MSAP 
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3.5 The Nicalin-NOMO complex beyond Nodal signaling 
 
The Nicalin-NOMO complex has been reported to have an antagonistic effect on Nodal 
signaling in zebrafish (Haffner et al., 2004). In situ hybridization experiments revealed similar 
spatiotemporal expression patterns of TMEM147 (this work), Nicalin and NOMO (Haffner et 
al., 2004) during zebrafish development underlining the functional relevance of their 
interaction. However, the lack of information about the cellular function of TMEM147 
prevented the further elucidation of the molecular role of the Nicalin-NOMO complex. 
Moreover, no factor with a known role in Nodal signaling was identified in the Nicalin 
interactome. Nodal function is believed to be mainly restricted to processes during and 
before gastrulation stages of chordate development (reviewed by Shen, 2007), but all 
complex components were also detected at later stages. In addition, they are widely 
expressed in various cell lines (Haffner et al., 2004, 2007; this work) and orthologs are 
present in invertebrates which lack Nodal signaling indicating that the complex might fulfill 
additional functions. In agreement with this, an involvement in invertebrate nicotinic 
acetylcholine receptor (nAChR) assembly has been proposed (Gottschalk et al., 2005; 
Almedom et al., 2009). nAChRs are homo- or heteropentameric ligand-gated ion channels 
involved in excitatory neurotransmission and muscle activation. They consist of α- and non-α- 
subunits, each contributing 4 transmembrane domains (TMDs), leading to a total of 20 TMDs 
in the assembled pentamer (reviewed by Albuquerque et al., 2009). The agonist, 
physiologically acetylcholine (ACh), binds at the interface between an α- and either another 
α- or a non-α- subunit (Chiara and Cohen, 1997). The binding of two or three ACh molecules 
is needed for maximal activation (Karlin, 2002; Cleary et al., 2005; Rayes et al., 2007). Thus, 
nAChR properties are affected by the number of α-subunits and the presence of certain 
subunits in the complex. In vertebrate muscle, α-, β-, γ-, δ- and ε-subunits exist, and nAChRs 
are of α2βγδ or α2βδε composition, depending on the developmental stage (Mishina, 1986). 
In vertebrate neurons, 9 α- and 3 β-subunits form an α5- or an α2β3-type receptor. In 
Caenorhabditis elegans (C. elegans), the nAChR subunit repertoire is even more complex, 
with 29 confirmed nAChR subunits (Jones et al., 2007). In 2005, a tandem-affinity-purification 
approach of C. elegans (ce) nAChRs led to the co-isolation of ceNicalin and ceNOMO 
(Gottschalk et al., 2005). A subsequent study (Almedom et al., 2009) demonstrated the 
existence of a Nicalin-NOMO complex and its ER-localization in C. elegans, and further 
showed that mutant animals lacking ceNicalin or ceNOMO proteins exhibited moderate, but 
specific, resistance to AChR agonists such as levamisole and nicotine. These cholinergic 
deficits were confirmed by whole-cell voltage-clamp analyses, where sensitivities towards the 
agonists were reduced (while the effects of the physiological ligand ACh were less clear). It 
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was further shown that in the absence of ceNicalin or ceNOMO the neuromuscular junction 
(connecting the axon terminal of a motoneuron with the motor end plate, i.e. the highly 
excitable region of the muscle fiber plasma membrane) contained nAChRs of different 
subunit composition, or altered relative amounts of different nAChRs with specific subunit 
compositions (particularly the subunits UNC-38 and UNC-29 were enriched, while ACR-8 
incorporation was reduced). Based on their findings, the authors proposed a model in which 
the Nicalin-NOMO complex acts as a ‘nucleation centre’ for nAChR assembly regulating the 
inclusion of particular subunits during pentamer assembly (Fig. 44, more details in legend).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Although most knockout animals tested were likely to be complete loss of function mutants, 
the phenotypes described were rather subtle, suggesting that a functional Nicalin-NOMO 
complex is not essential for survival, at least in nematodes. Interestingly, ceNicalin mutant 
phenotypes could be partially rescued by expression of the human homolog, indicating a 
possible conservation of the effect on nAChrR assembly. However, due to differences 
between vertebrate and invertebrate nAChR subunit composition (Jones et al., 2007) the 
relevance of the findings for the vertebrate system are unclear. Corresponding knockout 
models in vertebrates will have to be generated to elucidate the precise function of the 
Nicalin-NOMO complex in higher organisms.  
Of note, ceTMEM147 was not identified in the C. elegans study, which can be interpreted in 
two ways: either it is not required for the function of the Nicalin-NOMO complex in C. elegans 
or it was missed in the purification procedure. Based on the difficulties to identify TMEM147 
in the less complex purification scenario presented in this work, the latter possibility is 
favored and TMEM147 is expected to be a genuine complex component in all species. 
Fig. 44: Model of ceNicalin/ceNOMO function. Left, ceNicalin (Ncl)/ceNOMO influence either a) choice/assembly of particular 
subunits (indicated by different colors) of the pentameric nAChRs, or b) these proteins determine to which extent pentamers of 
a certain subunit composition are allowed to leave the ER (less favored, as no obvious accumulation of ceNicalin was observed 
at ER exit sites). Right, in the ceNicalin or ceNOMO mutants, nAChRs of other composition are found, for example, containing 
ACR-8 or UNC-29 subunits more often. Adapted from Almedom et al., 2009. 
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3.6 Outlook 
 
Although the existence of additional small components cannot completely be ruled out, it 
appears likely that all components of the Nicalin-NOMO complex have now been identified. 
Thus, the next challenge will be the characterization of its precise cellular/molecular function. 
From none of the three components - Nicalin, NOMO, and TMEM147 - a function could be 
inferred, as no enzymatic or other known motif could be identified in any of them. A general 
involvement of the complex in translocation and/or ER quality control has been suggested by 
preliminary data from this work and other studies. Indeed, such a role could explain the wide-
spread expression of the complex and its apparent involvement in two unrelated cellular 
processes, acetylcholine receptor assembly and Nodal signaling. Still, other possible 
functions of the Nicalin-NOMO have to be kept in mind, one being based on the observed 
interaction with a SNARE protein complex which is involved in ER homeostasis. In any case, 
the high degree of conservation of Nicalin, NOMO, and TMEM147 clearly points to an 
important function in multicellular organisms. For future analyses, the generation of further 
tools is required. In this work, a combination of SILAC, co-isolation and mass spectrometry 
was shown to offer a promising approach for the identification of novel Nicalin interactors, but 
the success may depend on the generation of an antibody which allows the precipitation of 
the intact complex from wild-type cells. Most importantly, loss-of-function animal models, 
especially in vertebrates, are needed. This work suggests that it is sufficient to target only 
one of the three genes to eliminate the complex. Likewise, a gain-of-function should be 
achieved solely by increasing Nicalin expression. These studies will not only contribute to the 
understanding of the function of the Nicalin-NOMO complex, but might also help to elucidate 
general mechanisms involved in the assembly of membrane protein complexes. One general 
conclusion from this work might be that the presence of small polytopic proteins in 
membrane protein complexes, like TMEM147 in the Nicalin-NOMO complex and APH-1 in γ-
secretase, could be an overlooked phenomenon, as their identification can be very 
demanding. 
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4.  Materials and methods 
 
4.1   Equipment 
 
37 °C incubator (Function line) Heraeus 
37 °C shaker (Certomat BS-1) B. Braun Biotech International 
Autoclave (Tuttnauer 3850 EL) Systec 
Bunsen burner (Vulcan)   Heraeus 
Cell lifter  Costar 
Centrifuge for large disposable tubes (Megafuge 1.0)  Heraeus, Kendro 
Centrifuge for disposable tubes (Biofuge pico) Heraeus, Kendro 
Centrifuge for disposable tubes / 4 °C (Biofuge fresco)  Heraeus, Kendro 
Centrifuge / 4 °C / swing rotor (Megafuge 1.0R) Heraeus, Kendro 
Centrifuge / 4 °C / swing rotor (Multifuge 3 L-R) Heraeus, Kendro 
Clean bench (Hera Safe HS12)  Heraeus, Kendro 
CO2 incubator (Hera cell) Heraeus, Kendro 
Disposable culture dishes (60 x 15 mm, 100 x 17 mm, 
    24 well, 12 well)  Nunc 
Disposable cuvette (10 x 11x 45 mm)  Sarstedt 
Disposable pipets (25 mL, 10 mL, 5 mL) Sarstedt 
Disposable tubes (50 mL, 15 mL, 2 mL, 1.5 mL, 
 0.5 mL, 0.2 mL) Sarstedt 
Electrophoresis chamber (Model B1; Model B2) Owl Separation Systems 
Electrophoresis cell (Mini-PROTEAN 3) BioRad 
Film developer (Curix 60)  Agfa 
Films (Super RX)   Fuji 
Freezer -80 °C (HFU 80) Heraeus 
Freezer -20 °C Electrolux 
Freezing tubes (Qualifreeze) Qualilab 
Gas burner (Vulcan) Heraeus, Kendro 
Glass pipet for gel loading Hamilton 
Heatblock Liebisch 
Incubator 37 °C (Function line) Heraeus  
Magnet stirrer (IKAMAG RCT basic and KMO2 basic)  IKA Labortechnik 
Microscope (Wiloverts 10 x 4/10/20)  Hund 
Microscope slides Menzelgläser 
Microwave Bosch 
N2 tank (Chronos) Messer Griesheim 
Needle (0.7, 0.9 mm diameter) Braun 
Pasteur pipets Sarstedt 
PCR machine (Mastercycler personal) Eppendorf 
pH-Electrode (Blueline 23 pH)   Schott 
pH-Meter (Inolab pH Level 1) WTW 
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Photometer (SmartSpecTM 3000)  Bio-Rad 
Pipet controler (Accu-Jet) Brand 
Power supply (Power Pac 300)  BioRad 
Pipet tips (1 mL, 200 µL, 20 µL, 2 µL) Sarstedt 
Quarz cuvette (10 x 10 x 45 mm, Quartz Spectrofotometer Cell)  BioRad 
Pipets with disposable tips (2 µL, 20 µL, 200 µL, 1,000 µL) Gilson 
Rotator (Roto-shake Genie) Scientific Industries 
Shaker (KM2)  Edmund Bühler 
Scale (Analytical+ 200 g - 0,0001 g)  Ohaus 
Scale (Standard 2000 g - 0,01 g)  Ohaus 
Syringe Terumo 
Table ultracentrifuge (Optima ultracentrifuge)  Beckman 
     TLA-55 rotor 
     MLA-80 rotor 
Beckman 
Beckman 
Transfer membrane (PVDF-Immobilon) Millipore 
Transfer chamber (Mini Trans-Blot Cell) BioRad 
Ultracentrifuge (L7-55)  Beckman 
     Ti 50 rotor Beckman 
UV lamp (White/ Ultraviolet Transilluminator)  UVP 
Vortex (Vortex Genie 2)  Scientific Industries 
Whatman paper Schleicher + Schuell 
Water deionizing machine (Milli-Q academic) Millipore 
Water bath (Typ 1002 ; Typ 1003)  GFL 
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4.2  Chemicals 
 
Acetic acid Roth 
Agar Becton Dickinson 
Agarose Amersham  
Ampicillin Roth 
APS (ammoniumperoxidisulfate) Sigma 
Bromophenol blue Fluka 
DDM (N-dodecyl-β-D-maltoside) Calbiochem/Applichem 
DMSO (dimethylsulfoxide)  Roth 
EDTA (ethylendiaminetetra-acetic acid) Merck 
Ethanol Merck 
Ethidiumbromide Sigma 
Formamide Merck 
Glycerol Roth 
Glycine Applichem 
H2Odest generated by water deionizing machine  
H2Odest for PCR H2Odest at 120 °C, 1.2 bar, 20 min autoclaved 
H2O2 (30 %) Merck 
Heparin Sigma 
I-Block blocking reagent  Applied Biosystems 
KH2PO4 Merck 
Methanol Merck 
2-Mercaptoethanol (β-Mercaptoethanol) Roth 
Mowiol 4-88 Roth 
NaCl Roth 
Na2HPO4 Merck 
NP-40/Igepal  Sigma 
Paraformaldehyde Sigma 
Poly-L-lysine Sigma 
Ponceau-S  
(3-Hydroxy-4-[2-sulfo-4-(4-sulfo-phenylazo)-
phenylazo]-2,7-naphthalene disulfonic acid) 
Sigma 
2-Propanol (Isopropanol) Merck 
SDS (sodium dodecyl sulfate) Serva 
TEMED (N,N,N’,N’-tetramethylethylendiamine) Roth 
Tetracycline Clontech 
Tris (Tris-(hydroxymethyl)-aminomethane) Applichem 
Triton X-100 Merck 
Xylene cyanol FF  
 
J. T. Baker  
 
 
Usually, chemicals were of purity grade p.a. (pro analysi). Chemicals not listed were 
purchased from Merck, Sigma or Roth in p.a. grade. 
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4.3 DNA techniques 
4.3.1  Plasmids 
 
Tab. 3 lists plasmids that were used in this thesis, while Tab. 4 gives details about those 
plasmids that were generated in this thesis. 
Name Description of plasmid Ref. 
pcDNA3.1(-) mammalian protein expression vector  (1) 
pcDNA3.1 Hygro(+) mammalian protein expression vector (abbreviation: pcDNA3.1) (1) 
pcDNA4/TO/myc-His A  mammalian protein expression vector (abbreviation: pcDNA4) (1) 
pcDNA6/V5-His A  mammalian protein expression vector (abbreviation: pcDNA6) (1) 
pcS2+ multipurpose protein expression vector (2) 
pLVTHM lentiviral shRNA expression vector (see section 4.4.5) (3) 
FUΔZeo lentiviral protein expression vector (see section 4.4.5) (4) 
pcDNA4/Ncl-myc encodes human Nicalin C-terminally fused to a myc/His-tag (5) 
pcDNA4/NclΔC-myc encodes human Nicalin w/o C-terminus (CT), fused to a myc/His-tag Tab. 4 
pcDNA4/NclΔTMC encodes human Nicalin w/o CT and transmembrane domain (TMD) Tab. 4 
pcS2+/zfNcl encodes Danio rerio Nicalin (5) 
pcDNA6/Nclmut-myc encodes RNAi-resistant human Nicalin C-terminally fused to a myc/His-tag (5) 
pcDNA6/Ncl-mutΔC encodes RNAi-resistant human Nicalin w/o CT Tab. 4 
pcDNA6/Ncl-mutΔTMC encodes RNAi-resistant human Nicalin w/o CT and TMD Tab. 4 
pcDNA4/NOMO-myc encodes human NOMO C-terminally fused to a myc/His-tag (5) 
pcDNA6/T147-V5 encodes human TMEM147 C-terminally fused to a V5/His-tag Tab. 4 
pcDNA4/zfT147-myc encodes Danio rerio TMEM147 C-terminally fused to a myc/His-tag Tab. 4 
pcS2+/zfT147 encodes Danio rerio TMEM147 Tab. 4 
FUΔZeo-T147mut-V5 encodes RNAi-resistant human TMEM147 C-terminally fused to V5/His-tag Tab. 4 
pcDNA3.1/CD4 encodes human CD4 (6) 
pcDNA3.1/CD4NC encodes human CD4, C-terminus exchanged for Nicalin C-terminus (NC) Tab. 4 
psPAX2 encodes lentiviral packaging proteins (gag, pol, pro; see section 4.4.5) (7) 
pcDNA3.1(-)-VSV-G encodes vesicular stomatitis virus G glycoprotein (see section 4.4.5) (8) 
pLVTHM-T147 encodes shRNA targeting human TMEM147 Tab. 4 
pLVTHM-Ncl encodes shRNA targeting human Nicalin Tab. 4 
pLVTHM-NOMO encodes shRNA targeting human NOMO Tab. 4 
 
Tab. 3: List of plasmids. Descriptions of vectors and their inserts as well as sources/references (Ref.) are given. References: 
(1) Invitrogen; (2) Rupp et al., 1994; (3) provided by Dr Peer-Hendrik Kuhn (LMU, Munich, Germany), generated from pLVTHM 
(Wiznerowicz and Trono, 2003) by modification of the ClaI site to a XmaI site; (4) provided by Dr Peer-Hendrik Kuhn, generated 
from FUGW (Lois et al., 2002) by exchanging GFP for a multiple cloning site and removing zeocin resistance (5) Haffner et al., 
2004; (6) Kaether et al., 2004; (7) provided by Dr Peer-Hendrik Kuhn, Addgene Plasmid 12260 (http://www.addgene.org); (8) 
provided by Dr Peer-Hendrik Kuhn, generated from pCMV-VSV-G (Addgene Plasmid 8454);  
 
Name Primers or Inserts Template Restriction  
pcDNA6/T147-V5 T147F and T147R cDNA HEK293T cells EcoRI/XhoI 
pcDNA4/zfT147-myc zfT147F and zfT147R  cDNA day 1 zf embryos EcoRI/XhoI 
pcS2+/zfT147 zfT147F and zfT147R cDNA day 1 zf embryos EcoRI/XhoI 
FUΔZeo/T147mut-V5 pcDNA31F and T147mutR; T147mutF and T147R-Not1  pcDNA6/TMEM147-V5 BamHI/NotI 
pcDNA4/NclΔC-myc NclF and Ncl-ΔC pcDNA4/Ncl-myc EcoRI/XbaI 
pcDNA4/NclΔTMC NclF and Ncl-ΔTMC pcDNA4/Ncl-myc EcoRI/XbaI 
pcDNA6/Ncl-mutΔC NclF and Ncl-ΔCStop pcDNA6/Nclmut-myc EcoRI/XbaI 
pcDNA6/Ncl-mutΔTMC NclF and Ncl-ΔTMC pcDNA6/Nclmut-myc EcoRI/XbaI 
pcDNA3/CD4NC CD4F and Ncl-CD4; CD4-Ncl and NclR-Not 
pcDNA3/CD4 
pcDNA4/Ncl-myc NheI/NotI 
pLVTHM-T147 T147.2v-F and T147.2v-R - MluI/XmaI 
pLVTHM-Ncl Ncl1531v-F and Ncl1531v-R - MluI/XmaI 
pLVTHM-NOMO NOMO2v-F and NOMO2v-R - MluI/XmaI 
 
Tab. 4: Details about DNA constructs generated in this thesis. The first nine entries are cDNA expression constructs. 
Primers, templates and restriction sites that were used for their generation are indicated. FUΔZeo-T147mut-V5 and 
pcDNA3/CD4NC were created by site-directed mutagenesis PCR: In a first step, 5’- and 3’-part of the insert were generated 
separately and a subsequent PCR was carried out using 5’- and 3’-parts together with the outer primers. The following three 
entries are pLVTHM-based shRNA expression constructs, which were generated by annealing denatured oligonucleotides in 
H2Odest for 15 min at 37 °C and cloning them into pLVTHM using MluI/XmaI restriction sites.  
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4.3.2 Oligonucleotides 
 
Tab. 5 lists the oligonucleotides that were used as PCR primers or annealed to generate the 
inserts of shRNA expression constructs. 
  
Name Sequence 
T147F 5’ GCGAATTCGGCATCATGACCCTGTTT-3’ 
T147R 5’-GCCTCGAGATAGGAGTGCACATTGACAAC-3’ 
zfT147F 5’-GCGAATTCACCATGACTCTTTTTCA-3’ 
zfT147R 5’-GCCTCGAGGTTGCTGTGGACGA-3’ 
pcDNA31fw 5’-CTCTGGCTAACTAGAGAAC-3’ 
T147mutR 5’-GTAGGCCAGGGCAAAACAATTCCCGAAGTGAAACAGGGTCATG-3’ 
T147R-Not1 5’-GATCGCGGCCGCTCAATGGTGATGGTGATG-3’ 
T147mutF 5’-GGAATTGTTTTGCCCTGGCCTACTTCCCCTACTTCATCACCTAC-3’ 
pcDNA31F 5’-CTCTGGCTAACTAGAGAAC-3’ 
Nicalin1531v-F 5’-CGCGACCCCGCAAGTGATGAATGCGTACTTCAAGAG AGTACGCATTCATCACTTGCTTTTTGGAAA-3’ 
Nicalin1531v-R 5’-CCGGTTTCCAAAAAGCAAGTGATGAATGCGTACTCTC TTGAAGTACGCATTCATCACTTGCGGGGT-3’ 
NOMO2v-F 5’-CGCGACCCCGTCGGACGTGGAGATCAACTTCAAGAG AGTTGATCTCCACGTCCGACTTTTTGGAAA-3’;  
NOMO2v-R 5’-CCGGTTTCCAAAAAGTCGGACGTGGAGATCAACTCTC TTGAAGTTGATCTCCACGTCCGACGGGGT-3’ 
T147.2v-F 5’-CGCGACCCCCTGCTTCGCTCTTGCCTACTTCAAGAGA GTAGGCAAGAGCGAAGCAGTTTTTGGAAA-3’ 
T147.2v-R 5’-CCGGTTTCCAAAAACTGCTTCGCTCTTGCCTACTCTC TTGAAGTAGGCAAGAGCGAAGCAGGGGGT-3’ 
T147R 5’-GCCTCGAGATAGGAGTGCACATTGACAAC-3’ 
T147F 5’-GCGAATTCGGCATCATGACCCTGTTT-3’ 
Ncl-qPCR-F 5’-ACCACCTGAGCCGCTACCTGAA-3’ 
Ncl-qPCR-R 5’-GACGGCCGGCTTGACTCTGT-3’ 
NOMO-qPCR-F 5’-AGCGGTGGGCCAGAACGACT-3’ 
NOMO-qPCR-R 5’-ACATCCCGGCAGCAATCCAC-3’ 
bAct-qPCR-F 5’-CTGGGACGACATGGAGAAAA-3’ 
bAct-qPCR-R 5’-AAGGAAGGCTGGAAGAGTGC-3’ 
CD4F 5’-GGTGCTAGCTTTCCAGAAGGCCTCCAGCATAGTC-3’ 
NclC-CD4 5’-TAGAGGAGGCTGAATGCTGGACACAGAAGAAGATGCC-3’ 
CD4-NclC 5’-GGCATCTTCTTCTGTGTCCAGCACTTCAGCCTCCTCTA-3’ 
NclR-Not 5’-GCGCGGCCGCTACTGTGTCTTGGCCTTCACGAG-3’ 
NclΔC 5’-GCTCTAGAGAGGAGGCTGAAGTGCTGGACAG-3’ 
NclΔCStop 5’-GCTCTAGACTAGAGGAGGCTGAAGTGCTGGACAG-3’ 
NclΔTMC 5’-GCTCTAGACTAGTCAAAGACGGCCGGCTTGA-3’ 
NclF 5’-GCGAATTCGGCCAGGATGCTGGAGGAA-3’ 
Tab. 5: List of oligonucleotides (all oligonucleotides were purchased from Thermo Electron, Ulm, Germany) 
 
 
4.3.3 RNA isolation and cDNA synthesis 
Total RNA from cultured human cell lines or day 1 zebrafish embryos were isolated using the 
RNeasy Kit (Qiagen). 4 µg of mRNA were used for the synthesis of cDNA using oligo(dT) 
primers and the SuperScript III First-Strand Synthesis SuperMix (Invitrogen). 
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4.3.4 PCR 
A typical polymerase chain reaction (PCR) contained the following components. 
 
Component Volume 
dNTP-Mix 1 µL 
forward primer (10 µM) 1 µL 
reverse primer (10 µM) 1 µL 
template (50 nM) 1 µL 
Pfu polymerase buffer 10x (Stratagene) 5 µL 
Pfu polymerase (Stratagene) 1 µL  
H2Odest for PCR (see 4.2.1) ad 50 µL 
 
Tab. 6: typical PCR reaction mixture 
 
PCR reaction mixtures were pipetted on ice and performed in a thermocycler using the 
following program.  
Temperature Periode 
95 °C 3 min 
30 cycles:  
     95 °C 30 sec 
     52 °C  60 sec/1,000 bp 
     70 °C 30 sec 
70 °C 10 min 
4 °C ∞ 
 
Tab. 7: PCR program 
 
 
4.3.5 Quantitative real-time PCR 
 
4 µg total RNA were used for the synthesis of cDNA using the SuperScript III First-Strand 
Synthesis SuperMix (Invitrogen) and oligo(dT) primers. 2.5 % of the cDNA were used for a 
SYBR Green (Bio-Rad) real-time PCR reaction (40 cycles with 15 s at 95 °C and 60 s at 65 
°C) on a Bio-Rad IQ5 machine. Primers for Nicalin (Ncl-qPCR-R and -F), NOMO (NOMO-
qPCR-R and -F), and TMEM147 (T147-R and -F) were used (see Tab. 5). Reactions were 
performed in triplets. The obtained CT values were normalized to β-actin expression (primers 
bAct-F and -R) by the comparative CT method (Livak and Schmittgen, 2001). 
 
4.3.6  Agarose gel electrophoresis  
Agarose gels: 
0.8 - 1.5 % agarose in TAE-buffer, ~3 min heated in the microwave (max. temperature), 0.2 μg/mL (final 
concentration) ethidiumbromide  
 
DNA loading buffer (6x): 
30 % Glycerin, 0.25 % Bromphenol blue, 0.25 % Xylencyanol FF in H2Odest   
 
TAE buffer 1x: 
242 g Tris, 57.1 mL acetic acid, 100 mL 0.5 M EDTA, H2Odest ad 1 
   
Depending on the size of the DNA to be separated, 0.8 to 1.5 % (w/v) agarose gels were 
applied using electrophoresis chambers from Owl Separation Systems (Models B1 and B2) 
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Electrophoresis was done in TAE buffer using a constant voltage of 120 volt. As a molecular 
marker, a 1 kb DNA ladder (Invitrogen) was used. If required, separated DNA fragments were 
extracted and purified using the Nucleo Spin Extract Kit (Macherey-Nagel).  
4.3.9 Restriction enzyme treatment 
Restriction enzymes (10 U/µL ; Fermentas): 
XhoI, EcoRI, BamHI, NotI, MluI, XmaI  
 
Restriction emzyme buffer (Fermentas): 
Y+ (Yello Tango) buffer 
 
Analytical restriction enzyme treatment for plasmid analyses was performed as follows. 
Component Volume 
Restriction enzyme (10 U/µL) 0.3 µL each 
Restriction enzyme buffer 1 µL or 2 µL 
DNA 500 ng 
H2Odest  ad 10 µL 
 
Tab. 8: Analytical restriction enzyme treatment 
Preparative restriction enzyme treatment for subsequent ligation was performed as follows. 
Component Volume 
Restriction enzyme (10 U/µL) 1 µL each 
Restriction enzyme buffer 8 µL 
DNA 4 µg 
H2Odest  ad 40 µL 
 
Tab. 9: Preparative restriction enzyme treatment 
 
Mixtures were incubated 1 h at 37 °C. After the reaction, cDNA fragments were isolated by 
agarose gel electrophoresis and purified using the Nucleo Spin Extract kit (Macherey-Nagel). 
4.3.10    DNA ligation 
 
100-300 ng vector, 0.3-1 µg cDNA fragment, 5 U T4 DNA ligase (5 U/µl) (Roche) and 2 µL T4 
DNA ligase buffer (Roche) were mixed with H2Odest at a final volume of 20 µL. The ligation 
mixture was incubated for 20 min at room temperature. 10 µL of the ligation mixture was 
used for transformation of competent bacteria (E.coli DH5α). 
4.3.11  Transformation of competent bacteria  
LB medium (Low Salt Luria-Bertani medium): 
1 % Trypton (Becton Dickinson), 0.5 % yeast extrakt (Becton Dickinson), 0.5 % Nacl, pH = 7.0, at 120 °C and 1.2 
bar for 20 min autoclaved 
 
LBAMP medium: 
LB medium, 100 µg/mL ampicillin (Roth) 
 
LBAMP agar plates: 
LB medium, 15 g/l agar (Becton-Dickinson) was added and at 120 °C and 1.2 bar for 2 min autoclaved. After 
chilling down to ~50 °C, ampicillin was added at a final concentration of 100 µg/mL. 
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50 µL of competent bacteria (E.coli DH5α, present in the laboratory) were added to ligation 
mixtures (or other DNA constructs to be amplified) and incubated for 30 min on ice. 
Subsequent heat shock treatment was done at 42 °C for 90 sec. Then the mixture was kept 
several minutes on ice. 450 µL of fresh LB-medium were added, followed by a regeneration 
step at 37 °C for 30 min while shaking. 100 µL were plated onto LB-agar plates containing 
100 µg/mL ampicillin (LBAMP agar plate), the rest was centrifuged at 7,000 rpm for one minute 
at RT, 300 µL of the supernatant were substracted, the pellet was resuspended in the 
residual liquid and plated onto another LBAMP agar plate. After o/n incubation at 37 °C, 
colonies were picked, inoculated into 3.5 mL of fresh LBAMP medium containing and 
incubated o/n at 37 °C. 3 mL of the culture were used for small scale DNA isolation. 
4.3.12     DNA isolation from bacteria 
3 mL of transformed E.coli DH5α o/n culture were used for small-scale DNA isolation using 
the Nucleospin Plasmid Kit (Macherey-Nagel). DNA concentration was measured by 
photometer. Correctness of the inserts was analyzed by restriction enzyme treatment and 
agarose gel electrophoresis. DNA was sent away for DNA-sequencing to GATC Biotech AG 
(Konstanz, Germany). For large-scale DNA isolation, small amounts of transformed E.coli 
bacteria were inoculated into 200 mL of LB medium containing 100 µg/mL ampicillin, and 
cultured o/n at 37 °C while shaking. Plasmid cDNA was isolated and purified from the o/n 
culture using the Nucleobond AX 500 Kit (Macherey-Nagel). DNA was resolved in H2O and 
the DNA concentration was measured by photometer.  
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4.4  Cell culture 
 
4.4.1  Cell lines 
Tab. 10 and 11 list wild-type and transgenic cell lines, respectively, which were used in this 
thesis. 
 
Cell line Description 
HEK293T human embryonic kidney cells 
HeLa human epithelial cervical cancer cells 
HepG2 human hepatocellular liver carcinoma cells 
A431 human epidermoid carcinoma cells 
SHSY5Y human neuroblastoma cells 
MCF7 human breast adenocarcinoma cells 
Panc-1 human pancreatic carcinoma cells 
C8161 human melanoma cells 
MDCK Madin-Darby canine kidney epithelial cells 
P19 mouse embryonic carcinoma cells 
3T3 mouse fibroblast cells 
N2A mouse neuroblastoma cells 
Tab. 10 List of wild-type cell lines. All cell lines were obtained from the laboratory’s cell line collection. 
 
Cell line Expression construct  Resistance Source/Reference 
T-Rex-293 (293TR)    Invitrogen 
293T/Ncl-myc pcDNA4/Ncl-myc zeocin (Haffner et al., 2004) 
293T/zfNcl pcS2+/zfNcl pcDNA6 blasticidin  
293T/NclΔC-myc pcDNA4/Ncl-ΔC-myc zeocin  
293T/NclΔTMC pcDNA4/Ncl-ΔTMC zeocin  
293T/Ncl-KD BSENU6-Ncl1531 zeocin (Haffner et al., 2007) 
293T/Nclrescue-myc BSENU6-Ncl1531 pcDNA6/Ncl-mutmyc zeocin (Haffner et al., 2007) 
293T/Nclrescue-ΔC BSENU6-Ncl1531 pcDNA6/Ncl-mutΔC zeocin  
293T/Nclrescue-ΔTMC BSENU6-Ncl1531 pcDNA6/Ncl-mutΔTMC zeocin  
293TR/Ncl-myc pcDNA4/Ncl-myc zeocin (Haffner et al., 2007) 
293T/NOMO-myc pcDNA4/NOMO-myc zeocin (Haffner et al., 2007) 
293T/NOMO-KD BSENU6-NOMO2 zeocin (Haffner et al., 2007) 
293T/NOMOrescue BSENU6-NOMO2 pcDNA6/NOMO-myc 
zeocin/ 
blasticidin (Haffner et al., 2007) 
293T/NOMO-myc/NclΔTMC pcDNA4/NOMO-myc pcDNA6/Ncl-mutΔTMC 
zeocin/ 
blasticidin  
293T/TMEM147-V5 pcDNA6/T147-V5 blasticidin  
293T/zfTMEM147-myc pcDNA4/zfT147-myc zeocin  
293T/NOMO-myc/ TMEM147-V5 pcDNA4/NOMO-myc FUΔZeo-T147mut-V5 zeocin  
293T/NOMO-myc/NclΔTMC/ 
TMEM147-V5 
pcDNA4/NOMO-myc 
pcDNA6/Ncl-mutΔTMC 
FUΔZeo-T147mut-V5 
zeocin/ 
blasticidin  
HeLa-pLVTHM pLVTHM   
HeLa/Ncl-KD pLVTHM-Ncl   
HeLa/NOMO-KD pLVTHM-NOMO   
HeLa/T147-KD pLVTHM-T147   
HeLa/T147-rescue pLVTHM-T147 FUΔZeo-T147mut-V5   
 
Tab. 11: List of transgenic cell lines. Stably inegrated DNA constructs, resistances and sources/references are listed. 
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4.4.2  Cell cultivation 
Trypsin-EDTA solution (Invitrogen): 
 0.05 % Trypsin, 0.53 mM EDTA-4Na  
 
penicillin/streptomycin solution (Invitrogen): 
 5,000 U/mL penicillin, 5 mg/mL streptomycin  
 
PBS (sterile): 
140 mM NaCl, 10 mM Na2HPO4,1.75 mM KH2PO4, pH 7.4 in H2Odest, autoclaved at 120 °C and 1.2 bar for 20 min 
 
Standard medium (Gibco Life Sciences): 
DMEM (Dulbecco’s modified Eagle’s Medium + 4500 mg/L Glucose + GlutaMAXTM I - pyruvate) supplemented 
with 10 % fetal calf serum (FCS; Invitrogen), 5 mL penicillin/streptomycin solution 
 
Selection medium zeocin: 
Standard medium + 200 μg/mL zeocin (Invitrogen) 
 
Selection medium blasticidin: 
Standard medium + 10 μg/mL blasticidin (Invitrogen) 
 
 
Cells were cultured in standard or selection medium in the presence of 5 % CO2 at 37 °C. 
Selection media contained 200 µg/mL of zeocin or 10 µg/mL of blasticidin. For passaging, 
the cells were washed once with autoclaved PBS, trypsinized for 5 min and appropriate 
amounts were seeded in fresh medium after well suspending. The expression of Nicalin in T-
Rex-293 cells was induced with 0.1 µg/mL tetracycline. 
 
4.4.3 Stable Isotope Labeling Using Amino acids in Cell Culture (SILAC) 
DMEM w/o Arg, Lys (SAFC Biosciences): 
Dulbecco’s Modified Eagle’s Medium (Modified) w/ 4500 mg/L glucose, w/ 4 mM L-alanyl-L-glutamine, 
w/ 110 mg/L sodium pyruvate, w/o L-arginine, w/o L-glutamine, w/o lysine 
 
SILAC medium 0,0: 
DMEM w/o Arg, Lys supplemented with arginine and lysine (Sigma-Aldrich), 10 % dialyzed fetal calf serum 
(Invitrogen), 5 mL penicillin/streptomycin solution 
 
SILAC medium 6,4: 
DMEM w/o arg, lys supplemented with 13C6-arginine (Sigma-Aldrich) and 5,5,6,6-D4-lysine (Sigma-Aldrich) 10 % 
dialyzed fetal calf serum (Invitrogen), 5 mL penicillin/streptomycin solution. 
 
 
To stably label all cellular proteins with isotope-labeled lysine and arginine, cells were 
cultivated in SILAC medium 6,4 (supplemented with 13C6-arginine and 5,5,6,6-D4-lysine) for 5 
passages (equivalent to 14 days). Control cells were cultivated in SILAC medium 0,0, 
containing unlabeled arginine and lysine (see section 2.9, Fig. 35, and section 4.7). 
4.4.4 Cell transfection 
Cells were cultivated until a confluence of ~90 % was reached. Then transfection was 
performed using the Lipofectamine 2000 transfection reagent (Invitrogen) following the 
  Materials and methods 
 
74 
manufacturer’s manual, except only half of the volumes and DNA amounts recommended 
were used (Tab. 12). First, DNA and Lipofectamine 2000 were each mixed with OptiMEM 
(Invitrogen) and incubated for 5 min at RT. Then the solutions were combined, further 
incubated for 20 min at RT, mixed with the standard medium and added gently to the cells.  
 
Culture 
vessel 
Plating 
medium 
Total cDNA and dilution 
volume 
Lipofectamine 2000 and dilution 
volume 
10 cm 10 mL 12 µg and 0.75 mL OPTMEM 30 µL and 0.75 mL OPTIMEM 
6 cm 5 mL 4 µg and 0.25 mL OPTIMEM 15 µL and 0.25 mL OPTIMEM 
12 well 1 mL 0.8 µg and 50 µL OPTIMEM 3 µL and 50 µL OPTIMEM 
 
Tab. 12: Tranfection mixtures 
 
For selection of stable single cell clones, 24-48 hrs after transfection the cells were diluted 
appropriately (e.g., 1:5, 1:10, 1:50, 1:100 and 1:1,000) in selection medium and plated. After 
growth for ~2 weeks, single cell clones were detached using sterile pipet tips and transferred 
into 24 well plates. After further expansion steps, clones expressing the target protein were 
selected based on the expression levels detected by immunoblotting. 
4.4.5  Cell transduction, lentiviral 
Lentiviral transduction of cells was carried out in cooperation with Drs Peer-Hendrik Kuhn 
and Stefan F. Lichtenthaler, DZNE (German Center for Neurodegenerative Diseases, 
Munich) and Adolf Butenandt-Institute, Biochemistry, Ludwig-Maximilians University Munich. 
Procedures were adapted from protocols described elsewhere (Wiznerowicz and Trono, 
2003; Lois et al., 2002). 
 
To generate stable knockdown cells, lentiviral supernatants were produced by transfecting 
low passage HEK293T cells (‘packaging cells’) with DNA constructs psPAX2, pcDNA3.1(-)-
VSV-G and either pLVTHM-T147, -Ncl or -NOMO (for construct details see Tab. 3-5, and 
Fig. 45). psPAX2 contains essential genes to generate infectious lentiviral particles, most 
importantly structural proteins (gag, group-specific antigen) and enzymes (pol, polymerase; 
pro, protease). pcDNA3.1(-)-VSV-G encodes fusogenic vesicular stomatitis virus G 
glycoprotein (VSV-G) to be presented at the viral envelope. pLVTHM-TMEM147, -Nicalin or -
NOMO were transcribed by the packaging cells to RNA molecules containing 1) the 
respective shRNA sequences driven by an H1 promoter, 2) the gfp (green fluorescent 
protein) gene (for selection) driven by an EF1α promoter, 3) lentiviral packaging 
signals/regulatory elements. Eventually, the packaging cell line released assembled VSV-G 
pseudotyped lentiviral particles that in their interior contained the respective RNAs as well as 
viral enzymes, most importantly reverse transcriptase (RT) and integrase. After o/n 
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incubation, the medium containing the viral particles was filtered through a 0.45-μm sterile 
filter and added to target cells. VSV-G mediated endocytosis and penetration of the 
endosome was followed by the release of lentiviral RNA and enzymes into the cytosol. Here, 
the RNA was reverse transcribed by RT to double-stranded DNA which was stably integrated 
into the genome by lentiviral integrase. Thus, stable shRNA-producing cell pools were 
obtained and GFP fluorescence could be used as a marker for transduction efficiency, which 
generally was close to 100 %. The procedure for the generation of TMEM147 rescue cells 
was identical except that for the transfection the FUΔZeo-TMEM147mut-V5 construct was 
used instead of pLVTHM-based shRNA constructs. 
 
 
 
 
 
 
 
 
 
4.4.6  Cell cryoconservation 
Freezing-medium: 
FCS containing 5 % (v/v) DMSO 
 
For cryoconservation, ~ 90 % confluent cells in 10 cm-dishes were trypsinized, washed in 
standard medium and pelleted. Pellets were suspended in 0.5 mL freezing-medium, 
transferred into a cryotube, frozen o/n at -80 °C and transferred into a liquid-nitrogen tank.   
gag pol pro tat/rev 
vsv-g 
gfp 
LTR 
shRNA 
LTR WPRE 
polyA 
polyA 
tmem147-V5 
LTR WPRE LTR 
H1 
CMV 
CβA 
psPAX2: 
pcDNA3.1(-)-VSV-G: 
PLVTHM-T147, -
Ncl, -NOMO: 
EF1α 
FUΔZeo-T147: 
Ub 
ψ 
ψ 
Fig. 45: Vectors for lentiviral transduction - coding and regulatory sequences. Only the most relevant structures are 
shown. psPAX2 contains essential lentiviral genes to generate infectious particles: gag (group-specific antigen) encoding 
elements of the viral capsid/nucleocapsid; pol (polymerase) encoding reverse transcriptase (RT) and integrase (see text); pro 
(protease) encoding the enzyme that cleaves the gag polyprotein precursor into its functional units; tat (transactivator of 
transcription); rev (regulator of expression of virion proteins), both encoding regulatory lentiviral proteins. pcDNA3.1(-)-VSV-G 
encodes vesicular stomatitis virus G glycoprotein (VSV-G), which became part of the viral envelope and enhanced infectivity. 
pLVTHM-T147, -Ncl or -NOMO were transcribed by the cellular machinery to larger RNA molecules containing the respective 
shRNA sequences, the gfp (green fluorescent protein) gene, lentiviral packaging signals (ψ), and regulatory elements, among 
them LTR (long terminal repeat) sequences, which are important for genome integration of the constructs. Upon co-transfection 
of these plasmids into low confluence 293T cells (‘packaging cells’), assembled lentiviral particles were released that presented 
VSV-G at their surface and in their interior contained the respective PLVTHM-encoded RNA molecules as well as viral enzymes, 
most importantly reverse transcriptase (RT) and integrase. Promoters, indicated by black arrows, are: CβA, chicken β-actin 
promoter; CMV, cytomegalovirus promoter; EF1α, elongation factor 1 α promoter; H1 RNA polymerase III promoter; Ub, human 
ubiquitin promoter. (polyA, poly-adenylation signal; WPRE, Woodchuck hepatitis virus post-transcriptional regulation element, 
improves the mRNA stability and compensates for the lack of poly-adenylation). Informations on plasmids were retrieved from 
www.addgene.com.  
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4.5   Protein analysis 
4.5.1 Antibodies 
Monoclonal Nicalin, NOMO, and TMEM147 antibodies were generated in collaboration with 
Dr Elisabeth Kremmer, HelmholtzZentrum, Munich, Germany. 
 
The monoclonal α (anti)-Nicalin antibody NiNT-1 was generated by immunizing rats with the 
peptide containing aa 43-58 of the human sequence and a C-terminal cysteine residue 
(AHEFTVYRMQQYDLQGC). Hybridoma cell supernatants were used 1:1000 for 
immunoblotting (1:5 to detect Nicalin in zebrafish lysates) and undiluted for 
immunofluorescence. The monoclonal α-NOMO antibody NOM4A12 was generated by im-
munizing rats with a peptide containing aa 923-938 of the human sequence and a N-terminal 
cysteine residue (CQYYFKPMMKEFRFEPS) and hybridoma cell supernatants were used 1:5 
for immunoblotting. The monoclonal α-TMEM147 antibody T147.11 was generated by 
immunizing mice with a peptide containing aa 124-140 of the human sequence and a C-
terminal cysteine residue (RGIEFDWKYIQMSIDSNC) and hybridoma cell supernatants were 
used 1:7 for immunoblotting. Tab. 13 lists all antibodies that were used. 
 
Antibody  Type Application  Source/Reference 
α-Nicalin (NiNT-1) rat monoclonal, hybridoma supernatant 
IB 1:1000, 1:5 (zf) 
IP 1:50  
IF undiluted 
Dr Elisabeth Kremmer, 
HelmholtzZentrum, Munich, 
Germany 
α-NOMO (NOM4A12) rat monoclonal,  hybridoma supernatant IB 1:5 Dr Elisabeth Kremmer 
α-TMEM147 (T147.11) mouse monoclonal, hybridoma supernatant IB 1:7 Dr Elisabeth Kremmer 
α-Calnexin rabbit polyclonal, pur. IB 1:5000  IF 1:500 Stressgen 
α-VCP mouse monoclonal, pur. IB 1:1000 Santa Cruz 
α-β-Actin rabbit polyclonal, pur. IB 1:1000  Sigma 
α-β-Catenin mouse monoclonal, pur. IB 1:1000  Sigma 
α-CD4 (EDU-2) mouse monoclonal, pur. IB 1:1000 DIATEC 
α-Sec22b rabbit polyclonal, pur. IB 1:1000 
Dr Mitsuo Tagaya, Tokyo 
University, Japan; 
(Hirose et al., 2004)  
α-Syntaxin 18 rabbit polyclonal, pur. IB 1:1000 Dr Mitsuo Tagaya; (Hatsuzawa et al., 2009)  
α-p31 (D12) rabbit polyclonal, pur. IB 1:1000 Dr Mitsuo Tagaya (Hirose et al., 2004) 
α-BNIP1 rabbit polyclonal, pur. IB 1:1000 Dr Mitsuo Tagaya (Nakajima et al., 2004)  
α-V5 mouse monoclonal, pur. IB 1:1000 IP 1 µL/1 mg ML Invitrogen 
α-myc (9E10) mouse monoclonal, ascites 
IB 1:2,000      
IP 0.25 µL/1 mg ML 
Developmental Studies 
Hybridoma Bank, Iowa 
University, USA 
α-flag (M2) mouse monoclonal, pur. IB 1:1000 IP 1 µL/1 mg ML Santa Cruz 
 
Tab. 13: List of primary antibodies. IB: immunoblot, IF: immunofluorescence, IP: immunoprecipitation, ML: membrane lysate, 
pur.: purified.  
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4.5.2  Total protein lysates 
PBS:   
140 mM NaCl, 10 mM Na2HPO4 and 1.75 mM KH2PO4, pH 7.4, in H2Odest 
 
High citrate buffer, 0.7 % DDM:  
50 mM NaCitrat, 1mM EDTA in H2Odest, 0.7 % (w/v) DDM, 1x PI mix 
 
High citrate buffer, 1 % NP-40:  
50 mM NaCitrat, 1mM EDTA in H2Odest, 1 % (w/v) NP-40, 1x PI mix 
 
PI mix (Protease inhibitors), 500x stock solution in DMSO (Roche) 
 
 
Cells adherent in culture dishes were washed with chilled PBS. and scraped off in 1 mL of 
chilled PBS with a cell lifter. The cell solution was transferred to a 1.5 mL disposable tube 
and centrifuged for 5 minutes at 1000 x g at 4 °C. The supernatant was removed and the 
pellet was lysed in high citrate buffer, 0.7 % DDM or 1 % NP-40, 1x PI mix and stored on ice 
for 15 min, followed by centrifugation (10 min, 17,000 rpm x g, 4 °C). The collected 
supernatant was the sample. Its protein content was detected via Bradford assay (1-2 µL of 
lysate mixed with 1 mL of BioRad protein assay working solution, incubated 5 min at RT, 
absorbance measured at 595 nm).  
 
4.5.3  Membrane protein lysates  
Low citrate buffer:  
15 mM NaCitrate, 1mM EDTA 
 
High citrate buffer, 0.7 % DDM or 1 % NP-40: see section 4.5.2 
 
 
Cells adherent in the culture vessels were washed with chilled 1x PBS (see section 4.5.2). 
Then a minimum of 1 mL of chilled PBS was added and cells were scraped off with a cell 
lifter. The cell solution was pipetted into 1.5 or 2 mL disposable tubes and centrifuged for 5 
minutes at 1000 x g and 4 °C. The supernatant was removed. The cell pellet was resus-
pended in low citrate-buffer + PI mix, 200 µL per 10 cm culture dish and 500 µL per 15 cm 
dish, respectively, and frozen in liquid nitrogen. The mixture was thawed on ice and the cells 
disrupted using a syringe with a 0.7 mm diameter needle (10 times). The suspension was 
centrifuged for 10 min at 1000 x g and 4 °C. The supernatant was centrifuged for 30 min at 
17,000 x g and 4 °C. The pellet was resuspended in an adequate volume of lysis buffer 
(usually High citrate buffer containing 0.7 % DDM) to achieve a protein concentration of ~10 
µg/µL (e.g., ~100 µL/ confluent 10 cm dish). Now the samples were incubated for 15 min on 
ice, centrifuged for 10 min at 13,000 rpm, 4 °C, the supernatant collected and its protein 
content detemined by a Bradford assay (see section 4.5.2). Typically, one confluent 10 cm 
culture dish yielded ~1 mg of membrane protein lysate, one confluent 15 cm dish ~3 mg. 
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4.5.4  Deglycosylation  
Deglycosylation experiments were carried out on membrane protein lysates (25 µg) 
containing 0.1 % SDS using 1 unit of N-glycosidase F (Roche) or 10 milliunits of 
endoglycosidase H (Roche) for 16 hrs at 37 °C.  
4.5.5  Immunoprecipitation (IP) 
For immunoprecipitation of myc-tagged Nicalin, V5-tagged TMEM147 or flag-tagged NOMO 
from stably transfected HEK293T cells, membrane protein lysates (concentration: ~10 µg/µL, 
but also less for immunoblot analyes) were used, typically containing 1 mg protein for im-
munoblot analysis, 3-5 mg for silver staining and 10-30 mg for Coomassie staining of SDS 
gels. The total volume was always more than ~50 % of the tube volume. Large-scale IPs 
from more than 10 mg starting material were performed in 10 mg aliquots. Preclearing was 
performed by addition of Protein G Sepharose 4 Fast Flow (Tab. 14) and shaking at 4 °C for 
a minimum of 2 hrs (also o/n). An appropriate amount of the respective antibody (Tab. 14) 
was added to the precleared lysates, followed by incubation for a minimum of 2 hrs while 
shaking at 4 °C (also o/n).  
 
Solution Application in IP Source 
α-myc 9E10 AB 2 µg/1 mg membrane lysate Hybridoma bank 
α-flag M2 AB 1µg/1 mg membrane lysate Santa Cruz 
α-V5 AB 1µg/1 mg membrane lysate Invitrogen 
PGS beads 1:2 in lysis 
buffer 
5 µL solution/1 mg membrane lysate, but 
a minimum of 20 µL 
(double amounts for preclearing) 
GE Healthcare 
 
Tab. 14: Solutions used for immunoprecipitation (IP) 
 
Finally, an appropriate amount of PGS beads (Tab. 14) was added, followed by incubation 
for 2 hrs (but not longer) while shaking at 4 °C. Washing of beads with bound material was 
performed by three times adding 200 µL of lysis buffer, resuspending the beads and imme-
diate centrifugation for 2 min at 1000 x g. Then ~40 µL 1x sample buffer (see section 4.5.7) 
were added. The 10 mg aliquots of large-scale IPs were eluted successively in the same 
sample buffer solution. The suspension was heated for 10 min at only 65 °C to prevent the 
aggregation of TMEM147. Typically, 30 µL were loaded onto a 14 % 0.75 mm SDS gel. 
As a molecular weight standard, 3-5 μL See Blue Plus 2 protein marker (Invitrogen) were 
used. Electrophoresis was carried out at 99 V and, after migration of the proteins into the 
separation gel, at 147 V. The separated proteins were either transferred to a PVDF mem-
brane (see section 4.5.8) or SDS gels were stained using either the Silver Stain Plus kit 
(BioRad) or the Coomassie PageBlue solution (Fermentas) according to the manufacturer’s 
manual.  
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4.5.6  Density gradient centrifugation 
PBS/20 mM EDTA:  
140 mM NaCl, 10 mM Na2HPO4 and 1.75 mM KH2PO4, pH 7.4, in H2Odest, 20 mM EDTA 
 
2x homogenization buffer (stock): 
20 mM HEPES pH 7.4, 2 mM EDTA, 0.5 M sucrose 
 
1x homogenization buffer:  
10 mM HEPES pH 7.4, 1 mM EDTA, 0.25 M sucrose 
 
Iodixanol solution 60 % (Sigma) 
 
For subcellular fractionation of cell membranes, a discontinuous iodixanol gradient was ap-
plied. For sample preparation, cells of 4 confluent 10 cm dishes were washed with chilled 
PBS (see section 4.5.2) and scraped in PBS/20 mM EDTA (2 mL per dish). Cells were pooled 
and centrifuged for 10 min at 1000 x g for 10 min at 4 °C. The supernatant was discarded 
and cells resuspended in 2 mL 1x homogenization buffer + PI mix. To crack cells, the 
suspension was passed 10 times through a 0.8 mm diameter needle. The suspension was 
aliquoted in two 1.5 mL disposable tubes and centrifuged for 10 min at 1000 x g for 10 min at 
4 °C. The resulting post-nuclear supernatants were transferred into polycarbonate tubes and 
centrifuged for 1h, 4 °C, at 40,000 rpm (Beckmann Optima, MLA-80 rotor). The resulting 
pellet was resuspended in 500 µL 1x homogenization buffer + PI mix and stirred o/n at 4 °C. 
400 µL were loaded onto the gradient, 100 µL were kept as starting material.  
For gradient preparation, a 30 % iodixanol working solution (WS) was prepared by mixing   
60 % iodixanol solution and 2x homogenization buffer 1:1. In a next step, 8 solutions of differ-
ent final iodixanol percentage were prepared by mixing working solution and 1x homogeniza-
tion buffer as follows (Tab. 15). 
 
Final iodixanol % WS (mL) 1x homog. buffer (mL) For 1 gradient 
2.5 0.21 2.29 1 
5 0.75 3.75 2 
7.5 1.125 3.375 2 
10 1.5 3 2 
12.5 0.625 0.875 0.5 
15 2.25 2.25 2 
17.5 0.875 0.625 0.5 
20 1 0.5 0.5 
30 (=WS) 1.5 0 0.3 
 
Tab. 15: Solutions of different final iodixanol percentage 
 
The solutions were underlayed in polyallomer tubes, with the 2.5 % iodixanol solution at the 
top and 30 % at the bottom. After samples (400 µL) were loaded, the tubes had to be filled 
up to 2 mm from the top with 2.5 % working solution and balanced to 0.01 g, The gradient 
was generated by centrifugation for 2 hrs 30 min at 40,000 rpm and 4 °C in a Beckman 
Optima ultracentrifuge equipped with a Sorval TH-641 rotor. Fractions were collected at 4 °C 
after placing the tube in a stand and piercing of the tube bottom using a 0.9 mm needle 
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(Braun). 12 x 1 mL fractions were collected in disposable tubes. For SDS-PAGE analysis, 20 
µL 6x sample buffer (see section 4.5.7) were added to 100 µL of each fraction and 25 µL 
were loaded. As a control, 4 µL of starting material were loaded. 
4.5.7  SDS-PAGE 
Acrylamide-Bis solution (Serva):  
40 % (w/v) Acrylamid/Bisacrylamid 37.5:1 in H2Odest 
 
Tris buffer 0.5 M:  
90.85 g Tris in 500 mL H2Odest, pH = 8.8 (adjusted using HCl) 
 
Tris buffer 1.5 M:  
30.28 g Tris in 500 mL H2Odest, pH = 6.8 (adjusted using HCl) 
 
Electrophoresis buffer: 
 25 mM Tris, 192 mM Glycine, 0.1 % (w/v) SDS, pH 8.3 
 
6x sample buffer:  
7 mL 0.5 M Tris-HCl with 0.4 % (w/v) SDS, pH 6.8, 3.6 mL glycerol, 1 g SDS, 600 µL 2-mercaptoethanol, 4 mg 
bromophenol blue, H2Odest ad 12 mL  
 
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed un-
der denaturing conditions using a discontinuous gel-system including one stacking and one 
separation gel (BioRad mini-gel system).  
Tab. 16Tab. 16 shows the composition of separating and stacking gels. To protein lysates 6x 
sample buffer was added. The mixture was heated for 10 min at only 65 °C to prevent the 
aggregation of TMEM147. 
 
Solution 7.5 % Separating gel 14 % Separating gel Stacking gel 
H2Odest 5.415 mL 3.8 mL 3.145 mL 
Tris buffer 1.5 M (pH 8.8) 2.5 mL 2.5 mL - 
Tris buffer 0.5 M (pH 6.8) - - 1.25 mL 
10 % SDS 100 µL 100 µL 50 µL 
40 % Acrylamide-Bis solution 1.875 mL 3.5 mL 0.5 mL 
10 % APS  75 µL 75 µL 50 µL 
TEMED 7.5 µL 7.5 µL 5 µL 
 
Tab. 16: Composition of (7.5 % and 14 %) separation and stacking SDS plyacrylamide gels. Amounts indicated are suffi-
cient for 2 mini-gels, 0.75 mm thick or 1 mini-gel, 1.5 mm thick.  
 
As a molecular weight standard, 3-5 μL See Blue Plus 2 protein marker (Invitrogen) were 
used. Electrophoresis was carried out at 99 V and, after migration of the proteins into the 
separation gel, at 147 V. For protein staining the the Silver Stain Plus kit (BioRad) or the 
Coomassie PageBlue solution (Fermentas) was used, for immunoblotting proteins were 
transferred to a PVDF membrane. 
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4.5.8 Transfer of proteins to PVDF membranes 
Transfer buffer:  
25 mM Tris, 192 mM Glycine, pH 8.3 
 
Ponceau-S solution:  
0.1 % (w/v) Ponceau-S, 5 % (v/v) acetic acid, H2Odest ad 100 mL 
 
Blocking solution (I-Bloc): 0,2 % I-Bloc (w/v) in TBST 
 
For the transfer of proteins to polyviylidene difluoride (PVDF) Immobilon-P membranes 
(Millipore) the Mini Trans-Blot Cell system (Bio-Rad) was used. PVDF membranes were 
soaked with 80 % (v/v) ethanol, washed with H2Odest, and incubated in transfer buffer for 
several minutes. The protein transfer was performed in transfer buffer for 1 h at 400 mA on a 
magnetic stirrer at 4 °C. After transfer, membranes were dried at RT and then again soaked 
with 80 % (v/v) ethanol. Membranes were stained using Ponceau-S solution. The stain was 
partially removed by washing in H2Odest, and membranes were blocked for 1 h at RT or over 
night at 4 °C in blocking solution. 
 
4.5.9 Immunological detection of proteins 
Tris-buffered saline/0.05 % Tween (TBST): 
10mM Tris pH 8.0, 150mM NaCl, 0.05 % Tween 20 
 
horseradish peroxidase (HRP)-coupled IgGs: α-rabbit (Promega), α-mouse (Promega), α-rat IgG (Santa Cruz) 
 
ECL Plus Western Blotting Reagents (GE Healthcare):  
Chemiluminiscence reagent A and B, mixed 40:1 
Blocked membranes were incubated with primary antibodies (see section 4.5.1) for 1 h at RT 
or o/n at 4 °C, washed 3 times for 10 min in TBST, incubated for 1 h at RT with horseradish 
peroxidase (HRP)-conjugated secondary antibodies, diluted 1:10,000 in blocking solution 
and washed again 3 times for 10 min in TBST. Signals were generated by ECL Plus Western 
Blotting Reagents (GE Healthcare) and were exposed on X-ray films (Super RX, Fuji) for an 
appropriate time span. 
4.6  Immunocytochemistry 
poly-L-lysine solution: 
100 µg/mL poly-L-lysine in H2Odest 
 
Mowiol:  
24 g glycerol, 9,6 g Mowiol 4-88, 24 mL dH20, 48 mL 0.2 M Tris, pH8.5  
 
 
Cells were grown on poly-L-lysine-coated (30 min poly-L-lysine solution, 3 washes with PBS) 
coverslips. Cells were fixed for 20 min with PBS/3.7 % paraformaldehyde, permeabilized 20 
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min with PBS/0.2 % Triton X-100, and blocked 1 h with PBS/1 % bovine serum albumine. 
Antibody incubations were performed for 1 h at room temperature in PBS using a humid 
chamber (for antibody details, see section 4.5.1). After washes with PBS, Alexa 488- and 
555-coupled secondary antibodies (Molecular Probes) were used for detection. After 
washing (3 times PBS, once H2Odest, once 80 % ethanol) and mounting in Mowiol, samples 
were analyzed with a Zeiss Axioplan) fluorescence microscope. 
4.7  Mass spectrometry 
 
Mass spectrometry (MS) analyses were performed in collaboration with Dr Marcus Krüger, 
Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany. 
 
Enhanced liquid chromatography-mass spectrometry (GeLC-MS) was essentially carried out 
as described (Kruger et al., 2008). Briefly, proteins were separated on a NuPAGE 4 %-12 % 
Bis-Tris gel (Invitrogen), stained with Coomassie Blue (PageBlue, Fermentas) and bands of 
interest were cut out. Proteins within gel pieces were subjected to alkylation and reduction, 
followed by trypsin cleavage. Then peptides were extracted as described (Shevchenko et al., 
2006) and both desalted and concentrated by Stage Tips (Thermo). Reverse-phase nano-
LC-MS/MS was performed using an Agilent 1200 nanoflow LC system (Agilent 
Technologies). The LC system was online coupled to a LTQ-Orbitrap (Thermo Scientific) 
which was equipped with a nanoelectrospray source (Proxeon). To identify proteins, the 
MASCOT database was searched using the following parameters: maximum of two missed 
trypsin cleavages, cysteine carbamidomethylation, methionine oxidation, and N-terminal 
protein acetylation (and SILAC labels Lys-D4 and Arg-6, for the SILAC experiment).  
For the analysis of the Nicalin interactom, MS was combined with SILAC (see section 4.4.3) 
and Nicalin-immunoprecipitation (Ncl-IP, see section 4.5.5). Fig. 35 in section 2.9 illustrates 
the workflow of the SILAC/Ncl-IP/MS experiment. 
4.8  Zebrafish techniques 
 
4.8.1 General 
 
E3 embryo medium: 
5 mM NaCl, 0,17 mM KCl, 0,33 mM CaCl2, 0,33 mM MgSO4, 0.1 % (w/v) methylene blue 
 
Experiments were carried out using the Danio rerio wild-type line AB (George Streisinger, 
Institute of Neuroscience, University of Oregon, USA) in compliance with the guidelines of 
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the Bavarian Council on Animal care. Zebrafish were maintained, raised, and mated as de-
scribed (Mullins et al., 1994). Embryos were kept at 28 °C in E3 embryo medium and staged 
as described (Kimmel et al., 1995).  
 
4.8.2 In situ hybridization 
 
20x SSC: 
3M NaCl, 0.3 M sodium citrate, pH 7.0 
 
hybridization (hyb) mix: 
50 % (v/v) formamide, 5x SSC, 50 µg/mL heparin, 500 µg/mL tRNA, 9 mM citric acid, 0.1 % (v/v) Tween 20 
 
PBT: 
 0.1 % Tween-20 in PBS (see section 4.5.2) 
 
Pi buffer: 
PBT containing 2 % (v/v) sheep serum and 0.2 % (w/v) BSA) 
 
AP (alkaline phosphatase) buffer: 
5 mL 1 M Tris pH 9.5, 2.5 mL 1 M MgCl2, 1 mL 5 M NaCl, 250 μL 20 % Tween-20 
 
NBT/BCIP stock solution (Roche): 
18.75 mg/mL NBT (Nitro blue tetrazolium chloride) and 9.4 mg/mL BCIP (5-Bromo-4-chloro-3-indolyl phosphate, 
toluidine salt) in 67 % DMSO (v/v). 
 
 
Digoxigenin-labeled RNA probes were synthesized using DIG RNA Labeling Mix, 10 × conc. 
(Roche) with the NotI-linearized construct PCS2+/zfTMEM as template for antisense probe 
synthesis using T7 polymerase, and EcoRI-linearized PCS2+/zfTMEM as template for sense 
probe (control) synthesis using SP6 polymerase. RNA in situ hybridization was carried out as 
previously described (Hammerschmidt et al., 1996). Day 2 embryos were bleached prior to in 
situ hybridization by incubation in 3 % H2O2/0.5 % KOH. Embryos were fixed for ~ 24 hrs in 
PBS/4 % PFA, manually dechorionated and dehydrated o/n in methanol at -20 °C. Then the 
embryos were rehydrated stepwise in methanol/PBT (90 %, 75 %, 50 %, 25 %, 10 % 
methanol) and finally put back in 100 % PBT (0.1 % Tween-20 in PBS). Embryos older than 
the beginning of somitogenesis were treated for 10 minutes with 10 µg/mL proteinase K 
(Roche) in PBT at RT, post-fixed in 4 % PFA for 20 minutes and then rinsed in PBT 5 times 
for 5 minutes each. Then they were prehybridized for 3 hrs at 70 °C in hybridization (hyb) 
mix, post-fixed in 4 % PFA and washed extensively followed by incubation in hyb mix for 3 
hrs at 70 °C. Probe hybridization was carried out o/n at 70 °C in hyb mix containing 50 ng to 
100 ng of probe. Unbound probe was removed in a series of washes at 70 °C: 10 minutes in 
75 % hyb mix/25 % 2x SSC, 10 minutes in 50 % hyb mix/50 % 2x SSC, 10 minutes in 25 % 
hyb mix, 75 % 2x SSC, 10 minutes in 2x SSC, 2 times 30 minutes in 0.2x SSC. Further 
washes were performed at RT for 5 minutes in 75 % 0.2x SSC/25 % PBT, 5 minutes in 50 % 
0.2x SSC/50 % PBT, 5 minutes in 25 % 0.2x SSC/75 % PBT and 5 minutes in PBT. In the 
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next step, embryos were blocked for 1 h in Pi buffer and incubated o/n at 4 °C with pre-
adsorbed alkaline phosphatase-coupled anti-digoxigenin Fab fragments (Roche) at a 1:5000 
dilution in Pi buffer. Finally the embryos were washed 6 times for 15 minutes each in PBT at 
room temperature and once in AP buffer. Detection was performed using NBT/BCIP stock 
solution diluted 1:50 in AP buffer. When the color was developed, the reaction was stopped 
by several washes with PBT. Embryos were transferred to glycerol and photographed using 
a Zeiss Axioplan 2 imaging compound microscope. 
 
4.8.3 Zebrafish total protein lysates 
10 embryos or larvae were frozen in 300 µL of 1x sample buffer (see section 4.5.7). After 
thawing, samples were heated for 5 min at 60 °C and homogenized by sonification (5 
strokes), followed by 5 min at 60 °C. 10 % of the lysate were subjected to an SDS-PAGE.  
4.9  Bioinformatical methods 
 
Tab. 17 lists the databases and bioinformatical programs that were used, applications are 
characterized and web addresses are shown. 
 
Application Database/Program Web address 
mRNA, genomic DNA and protein 
database NCBI http://www.ncbi.nlm.nih.gov/ 
protein database Uniprot http://www.uniprot.org 
RNA expression (expressed sequence 
tag, EST) database GeneNote 
http://bioinfo2.weizmann.ac.il/cgi-
bin/genenote/home_page.pl 
search of orthologous proteins and 
identity calculation FASTA http://www.ebi.ac.uk/Tools/fasta33/ 
interspecies multiple protein alignment clustalw2 http://www.ebi.ac.uk/Tools/clustalw2/ 
interspecies multiple protein alignment 
visualization Jalview http://www.jalview.org 
overall protein hydrophobicity 
calculation ProtParam http://expasy.org/cgi-bin/protparam 
global protein alignment 
EMBOSS by the 
Needleman/Wunsch 
algorithm 
http://www.ebi.ac.uk/Tools/emboss/align/ 
local protein alignment 
EMBOSS by the 
Smith/Waterman 
algorithm 
http://www.ebi.ac.uk/Tools/emboss/align/ 
membrane protein topology prediction PRODIV-TMHMM http://topcons.cbr.su.se 
signal peptide determination Signal P 3.0 http://www.cbs.dtu.dk/services/SignalP/ 
N-linked glycosylation 
prediction NetNGlyc 1.0 http://www.cbs.dtu.dk/services/NetNGlyc/ 
global protein analysis SMART http://smart.embl-heidelberg.de/ 
protein domain analysis Pfam http://pfam.sanger.ac.uk 
generation of protein hydrophobicity 
plots 
Protscale by the Kyte-
Dolittle method http://www.expasy.ch/tools/protscale.html 
transcription factor binding site 
prediction PROMO 8.3 
http://alggen.lsi.upc.es/cgi-bin/promo_v3/ 
promo/promoinit.cgi?dirDB=TF_8.3 
identification of proteins from mass 
spectrometry data  MASCOT database  http://www.matrixscience.com 
 
Tab. 17: Databases and bioinformatical programs 
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6.  List of abbreviations 
 
(Abbreviations are also explained in the text by their first appearance. Therefore, only 
abbreviations that were used more than once are listed.) 
 
α-   anti- 
aa    amino acid 
Aβ    amyloid β- (Aβ-) peptide 
AB   antibody 
AD    Alzheimer's disease 
APH-1 (aL, aS, b) Anterior Pharynx-Defective 1(a long isoform, a short isoform, b) 
AP   aminopeptidase 
APP    β-amyloid precursor protein 
AU   arbitrary units 
bp   base pairs 
°C    centigrade 
CO2    carbon dioxide 
C-terminus   carboxy-terminus (of a protein) 
cDNA   coding desoxyribonucleic acid 
ce   Caenorhabditis elegans 
co-IP    co-immunoprecipitation 
DAP   DYIGS and peptidase hydrophobic region 
dest   distilled 
DMEM   Dulbecco’s Modified Eagle Medium 
dNTP    desoxyribonuceic acid triphosphate 
DNA   desoxyribonucleic acid 
E. coli    Escherichia coli 
ER    endoplasmic reticulum 
et al.   et alii (and others)  
FAD    familial AD 
FCS   fetal calf serum 
Fig.   figure 
g   gram or Earth's gravity 
h, hrs   hour, hours 
H2O    water 
HEK    human embryonic kidney 
HeLa   Henrietta Lacks human epithelial cervical cancer cells 
Ig   immunoglobulin 
IgG   immunoglobulin, class G 
IP    immunoprecipitation 
KD   knockdown 
kDa   kilo-Dalton 
L   liter 
M    molar 
mM    millimolar 
µM   micromolar 
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µg   microgram 
mg   milligram 
min   minute 
µL   microliter 
mL   milliliter 
mRNA   messenger ribonucleic acid   
N-terminus   amino-terminus (of a protein) 
Ncl, Nicalin  Nicastrin-like protei
ng   nanogram 
n 
nM   nanomolar 
NCT   Nicastrin 
Nicalin   Nicastrin-like protei
NOMO   
n 
Nodal mo
NOMO-L  
dulator 
Nodal mo
o/n   over night 
dulator, long isoform 
OD   optical density  
PAGE    polyacrylamide gel electrophoresis 
PBS    phosphate-buffered saline 
PCR   polymerase chain reaction 
PEN-2   Presenilin-Enhancer 2 
PI    protease inhibitor(s) 
PS   Presenilin 
PS1    Presenilin 1 
PS2    Presenilin 2 
RNA   ribonucleic acid 
RNAi    RNA interference 
rpm   revolutions per minute 
RT   room temperature 
SDS    sodiumdodecylsulfate 
SDS-PAGE  sodiumdodecylsulfate polyacrylamide gel electrophoresis 
sec   second(s) 
SP   signal peptide 
T147, TMEM147 Transmembrane Protein 147 
Tab.   table 
TBST    tris-buffered saline +Tween 
TGFβ    transforming growth factor β 
TM    transmembrane 
TMD   transmembrane domain 
U    unit (enzyme unit) 
UV   ultraviolet 
v/v    volume/volume 
w/v    mass/volume 
wt   wild-type 
zf   zebrafish  
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Amino acids: 
 
A   alanine 
C   cysteine 
D   aspartate 
E   glutamate 
F   phenylalanine 
G   glycine 
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I   isoleucine  
K   lysine 
L   leucine 
M   methionine 
N   asparagine 
P   proline 
Q   glutamine 
R   arginine 
S   serine 
T   threonine 
V   valine 
W   tryptophane 
Y   tyrosine 
 
 
Nucleosides: 
 
A   adenosine, deoxyadenosine 
C   cytidine, deoxycytidine 
G   guanosine, deoxyguanosine 
T   thymidine (= deoxythymidine) 
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